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ABSTRACT 
The pineal gland, a biochemically very active neuroendocrine transducer 
which is innervated by the sympathetic nervous system, was used in vivo 
to evaluate the effect of different ~-adrenoceptor agonists and 
antagonists on pineal enzyme levels. 
Hydroxyindole-O-methyltransferase (HIOMT), an enzyme wi th a circadian 
activity and unknown control was not signi ficantly affected by these 
drugs. The activity of serotonin N-acetyltransferase, another pineal 
enzyme with a greate- amplitude of circadian r hythmicity and which is 
under norad~energic neur al cont r ol, was greatly enhanced by ~-adreno-
ceptor agonists. This effect could be blocked by ~-adrenoceptor 
blocking agents, the degree of blockade depending on the selectivity 
and affinity of the agent used. 
An attempt was also made to alter the oestrous cycle of the rat by 
dosing with ~-active substances. Only propranolol had any effect on 
the oestrous cycle. It was not possible to establish an absolute link 
between the alteration in pineal enzyme activity and an influence on the 
oestrous cycle. It was concluded that the pineal enzyme studies are 
useful pharmacological means for evaluating ~-active substances. 
1.1 PINEAL ANATOMY 
CHAPTER 1 
LITERATURE REVIEW 
1.1.1 Pineal Innervation and Blood Supply 
The pineal gland of the rat is situated between the two cerebral hemi-
spheres of the brain, just forward of the cerebellum; viewed laterally, 
it is superficially located just below the skull (fig. 1). It derives 
its name from the pine cone which it resembles in shape. In the rat , 
the pineal gl and has a mass of about 1 mg. It is covered by the 
confluence of the superior sagittal sinus and the transverse sinus. 
The gland is supported by strands of connective tissue which attach it 
to the t'ela chorioidea rostral l y and t o the inferior surface of the 
t ransverse sinus caudally (fig. 2). In the rat, relay of sensory 
information to the pineal takes place via nerve fibres; the majority 
of these fibres are sympathetic and originate bilaterally in the 
superior cervical ganglion (Kappers , 1960). These penetrate the pineal 
as the nervi conarii in two bilateral symmetr i cal nerve tracts. Some 
nerves enter the pineal along small pial vessels (fig. 2). After 
leaving the tentorium cerebelli, the nerves enter the pineal symmetrically 
at the dorso- caudal surface of the organ just beneath the floor of the 
confluens sinuum. At this point , two symmetrical branches of the 
posterior cerebral arteries usually enter the organ. 
main source of blood supply to the pineal. 
These are the 
A small number of nerves travelling up the pineal stalk carry direct 
information from the brain (fig . 1), but these are generally considered 
to be merely aberrant neurons arising from the habenular commissure and 
posterior commissure with no functional significance (Clark , 1940). 
However, Gardner (1953) has suggested that these nerves which are 
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Fi g. 1. Lateral view through the midplane of the adult rat brain 
indicating location of the pineal gland and sympathetic nervous 
innervation. 
C, cerebellum; P, pineal gland; ce, corpus callosum; V, veins; 
PS, pineal stalk; M, medulla; N, nerves from superior cervical ganglia 
(Wurtman and Axelrod, 1965). 
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derived from the commissures may have some functional significance . The 
so-called Fibrae pineales,ventrales or poster i or es reach the organ from 
the caudal or posterior commissure. Fibrae prepineales, pineales 
superiores , anteriores or dorsal es arise from the habenular commissure. 
It is now generally accepted that these fibres from the commissures have 
thei r cells of origin in the brain (Kappers, 1965) . Owing to di ff iculty 
in tracing these nerve pathways , it has been referred to as the "habenul o-
caudo-commissural epiphysial system " or the "epithalamico-epiphyseal 
tract" (fig. 2 ). 
1.1. 2 The Pineal Stalk 
The pineal stal k develops by growing out of the most proximal part of the 
rostro- dorsal and caudo- ventral area of the pineal. The stalk consists 
of pinealocyt es which show a follicular arrangement i n some plac es , as 
well as pinealoblasts and fibrocytes. The stalk can be divided into 
three parts , a proximal- , a mid- and a distal part. At the midpart the 
stal k is often very thin (Kappers, 1960) . Some nerve fibres from the 
commissures form loops and pass back down the sta lk . Some however may 
penet rate deep into the pineal and some may pass on to neighbouring 
tissues (Kappers , 1965) . There do no t seem to be any afferent nerves 
originating in the pineal and going to t he brain (fig. 3). 
Dafny ( 1977) found electrophysiological evidence of reciprocal c entral 
connections between the pineal and the ventromedial hypothalamus as wel l 
as the existenc e of pineal inputs from acoustic , ol factory, photic and 
amygdaloid pathways . 
habenular commissure . 
These pathways are thought to originate in t he 
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ISS 
OPA 
Fig. 2. Diagrammatic representation of the blooi and nerve supply 
of the rat pineal gland. 
ISS , inferior sagittal sinus; VG, great vein of Galen; SS, straight 
sinus; DPA, dorsal pineal artery; TS, transverse sinus; PA, pial 
arteries to the pineal; CT, connective tiss~e strands supporting the 
pineal; TC, tela chorioidea; EE, epithalami co-epiphyseal nerve 
fibres; SF, sympathetic nerve fibres; HC, habenular commissure; 
PC, posterior co~miss~re (Gardner, 1953). 
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Matsushima et al. (1977) showed that large bundles of unmyelinated nerve 
fibres penetrate the pineal gland through relatively wide intercellular 
spaces. The nerve fibres and endings are situated mainly within these 
intercellular or peri capillary spaces. These nerve endings contain small 
granulated and non-granulated vesicles of about 50 nm in diameter as well 
as a few larger granulated ones of about 100 nm in diameter . The presence 
of these vesicles indicates that the nerve fibres here are probably 
sympathetic adrenergic postganglionic in nature, with their cel l bodies 
located in the superior cervical ganglia (Pellegrino de Iraldi et al., 
1965) . Axonal dilations have also been observed in the pineal gland. 
These contain inclusions such as mitochondria and vesicles . The swellings 
are found mainly within the pineal parenchyma , surrounded by parenchymal 
cells and less of ten in pericapillary spaces (fi g . 4a and 4b). 
Bulbous nerve terminals lying adjacent to pineal c apillaries were also 
described by Milofsky (1957) . These terminals contain many small 
vesicles most of which enclose a dense granule. Pellegrino de Iraldi 
et a l. (196 1 ) , using electron microscopy, observed pinealocytes with 
club-shaped per i vesicular expansions connected to the cell body by thin 
pedicles. These expansions were seen to be rather large pericapillary 
spaces. It was assumed that these expansions may contain biogenic 
amines . Reserpine causes heterogeneous granular vesicles to disappear 
almost entirely , suggesting therefore that they are storage sites for 
biogenic amines. These club- shaped terminals are now considered to be 
autonomic nerve endings. 
Wolfe et al. ( 1962 ) has shown that noradrenaline is stored or associated 
in pineal autonomic nerves and endings . The neurotransmitter, most 
probably noradrenal ine, released from the neuronal varicosities, stimulates 
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Fig. 3 . Aberr ant commissural- epiphyseal fibre making a hair-pin loop 
in the most rostral part of the rat pineal body, X800 (Kappers , 1965 ). 
Fig . 4a. Probable autonomic Fig . 4b . Representation of an axonal 
nerve terminals in pineal dilation consi dered to be an autonomic 
parench yma X800 (Kappers , nerve ending , adjacent to a pineal cell. 
1965 ) • 
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the parenchyma cells or pinealocytes by diffusing through t he basement 
membrane lining the pineal parenchyma. Intraparenchymal sympathetic 
fibres end in close contact wi th processes of pinealocytes and their 
terminal buds, but never on the bodies of these cell s. 
1. 1.3 The Pineal Cel l 
The mammalian pinealocyte is a secretory cell which produc es , stores and 
secretes different pineal substances. Storage, and possibly also part 
of the production of secretory substances, occurs in the terminal buds 
of the pi nealocyte processes . These buds usual l y t erminat e either on 
the basement membrane of the pineal parenchyma or on intercellul ar spaces 
whi ch communicate with the pericapillary spaces . 
It seems that pinealocytes secrete their products into the blood circulating 
in the capillaries via the basement membrane of the pineal parenchyma, the 
peri capillary space, the basement membrane which covers the capillary 
endothelium and the endothelial wall. Secretion also occurs from the 
parenchyma into intercellular spaces which are in open communication 
with the pericapi llary spaces . Sympathetic nerve endings are by no means 
l imited to areas around a capillary , but have also been observed e i ther 
within the pineal parenchyma or adjacent to the terminal clubs indi cat ing 
that the function is no t merel y the regulation of bloodflow through the 
pineal. 
Although synapse-like structures have not been observed between nerve 
endings and pinealocytes , there is a c l ose relationship between them. 
It is possible that a nerve impulse may spread from an innervated termi nal 
club to adjacent terminal clubs by means of low- resistance pathways . 
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Indoleamines such as serotonin have been detected in pinealocytes by 
f luorescence microscopy (Owman, 1964). However, the ultrastructural 
location of melatonin and serotonin remains to be clarified. 
1.1.3.1 Structure of Pineal Cells 
The main type of cell in the rat pineal accounting for almost 90% of the 
cell popula tion is the epiphyseal cell. It has also been called 
"parenchymal !!, " gl andular II and "fundamenta l ". The other element 
constituting the remainder of the pineal is a distinctive population 
of interstitial cells. They are so named because this describes their 
disposition in pineal tissue. The number and situation of these cells 
suggests that they correspond to most of the "neuroglial cells" (usually 
astrocytes) traditionally described in the pineal (Wolfe, 1965) . 
Pineal cell clusters tend to be haphazard (fig. 5) . Cytoplasmic 
prolongations or polar processes arise from the perikaryon of a pineal 
cell and taper to a neck-like or collicular segment. A polar process 
is joined to adjacent pineal cells by a particular type of intercellular 
junction called zonula or fascia adhaerens (Farquhar and Palade, 1963). 
The fine structure of polar processes suggests that they are homologous 
to the club-shaped prolongations of pineal cells in the human pineal body. 
Pineal cells in a cluster are tightly grouped , a gap of about 15 to 25 run-
separating most cells. Sometimes these clefts widen abruptly, forming 
an interfacial lake (fig. 5). 
The epiphyseal nucleus has the fine structur e of interphase nuclei of 
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Fig. 5 . Typical epiphyseal cluster showing compact cell arrangement. 
P, periva~cular space; L, circumluminal array; F , interfacial lake; 
EC, epiphyseal cells; ld, lipid droplets; R, erythrocyte; cs, collicular 
segments of polar processes; ds , distal segments of polar processes ; 
gm, giant mitochondria; ne , pineal nuclei; ni, interstitial cell nuclei 
X5200 (Wolfe, 1965). 
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many tissues (Bernhard and Granboulon, 1963). The nucleoplasm is highly 
electron-lucent . Chromatin is localized in an uneven marginal zone 
sporadically confluent with areas deeper in the nucleus . Chromatin 
areas are filled with areas of low electron density which are arranged 
in granular and variegated masses and thi n he l i cal strands. Nucleoli 
probably also exist in all pineal cell nuclei , their marked electron-
density contrasting with the relatively uniform appearances of the 
remaining nucleoplasm and cyt opl asm (fig . 6). 
Single ribosomes and c l usters of 4 to 12 ribosomes are sprinkl ed through-
ou t the cyt oplasm and are not associated with membranes . A small number 
of ribosomes are associated with paired cytoplasmic membranes and with 
the outer layer of the nuclear envelope to form the rough surfaced or 
granul ar endopl asmic reticulum of the pineal cell. Cytoplasmic membranes 
are rarely observed in their full complexity due to tbe disruptive action 
of preparative techniques for electron microscopy (Wolfe, 1965) . 
Pineal cells contai n a large number of lipid incl usions which vary widely 
in shape. Cl ose to t he lipid droplets , mat erial of similar e l ectr on 
density i s frequent l y present within cisternae of the endoplasmic 
reticulum . 
Pineal cells have a fa i rly abundant number of mitochondria varying markedly 
in size (fig. 5). Zig-zag arrays of cristae are sparse in the mitochondria 
(Revel et al. , 1963). 
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Fi g. 6. Pineal cell nucleus showing pattern of chromatin in the 
marginal (mc) and perinucleolar chromatin areas. 
nu, nucleolonema; ig , interchromatin granules; IS, interstitia l 
space. Nuclear pores are arrowed. (Wolfe, 196 5) . 
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These are irregular convolutions of lamellae surrounding a central zone 
of ill- defined granular material in which lipid droplets , glycogen particles, 
mitochondria and vesicles are present. 
pineal c ell cytoplasm. 
The whorled lamellae may be part of 
Filaments about 8 nm thick are common in autonomic axons and interstitial 
cells but are rare in epiphyseal cells. 
The presence of a microtubul ar arrangement is the most distinctive cytoplasmic 
component of the pineal c ell. 
randoml y in epiphyseal cells. 
Membranes of t he Golgi apparatus occur 
tlGrumose bodies ll , common in pineal cells 
usually contain finely- textured granular material distributed evenly in 
a dense amorphous matrix . 
terminals (Wolfe , 1965) . 
1.1.4 Blood Flow 
These bodies usually populate the polar 
By using an isotope indicator method,Goldman and Wurtman (1964) clarified 
the nature of blood flow in the pineal. The rate of flow was found to 
be at least 2 to 4 ml/min/g . This rate of flow through the pineal is 
higher than in most other endocrine organs; it is equalled by that of 
the neurohypophysis and surpassed only by the rate of flow through the 
kidney. 
1. 2 PINEAL BIOCHEMISTRY 
1. 2. 1 Melatonin Biosynthetic Pathway 
For an organ of such small size, the rat pineal gland is of extreme 
- 13 -
biochemical significance. The initial stimulus to study its physiology 
and biochemistry was provided by Lerner (1958) when he isolated and 
characte~ized melatonin . Melatonin is regarded as the primary pineal 
indoleamine . It is synthesized in the organ as shown in fig. 7. 
These biosynthetic conversions are under the sympathetic neural control 
of the nerves arising from the superior cervical ganglia (Volkman and 
Heller , 1971; Wur t man et al ., 1971; Zatz et al ., 1976). It has been 
shown tha t the sympathetic nerve endings contain noradrenaline , serotonin 
and histamine (Giarman and Day , 1959). Noradrenaline is released to act 
on ~-receptors in the pineal gland (Axelrod et al. , 1969) and thus 
influences the metabolic processes in the gland . The precursor in the 
biosynthesis of melatonin (fig. 7) is tryptophan , an amino acid . The 
uptake of tryptophan by the pineal parenchymal cells is enhanced by 
nervous stimUlation whic h results in a greater re l ease of noradrenaline 
(Wurtman et al ., 1969 ). Tryptophan i s then hydroxylated by the enzyme 
tryptophan hydroxylase to form 5- hydroxytryptophan (Lovenberg et a l., 
1967) • Another enzyme , aromatic-L-amino acid decarboxylase , catalyses 
the formation of 5- hydroxytryptamine or serotonin (Snyder and Axelrod , 
1964a) This enzyme has a concentration in the pineal greater than in 
any other tissues exami ned (Snyder and Axelrod, 1964b ). Another enzyme 
serotonin- N- acetyl transferase (SNAT) transfers an acetyl group from 
acetyl coenzyme A to form N-acetylserotonin (Weissbach et a l., 1960). 
The final step of mel atonin synthesis, i.e. O-methylation in the 5 
posi t ion , takes place in the presence of the enzyme hydroxyindole- O-
methyltransferase (HIOMT )(Axel rod and Wei ssbach, 1960 ; 1961). 
1.2.2 Secondary Indole Pathways 
There are also a number of secondary indole metabolic pathways in the 
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MELATONIN BIOSYNTHEI'IC PATHWAY 
TRYPTOFHAN 
N-ACEI'YLSEROTONIN 
HIOMT 
N-ACEI'YL-5-MEI'HOXYTRYFTAMINE 
(MELATONIN) 
Fig . 7. 
~H2 
_T,-RY_PTO_FH_AN_----tl> HO~C HrC H-COO H 
HYDROXYLASE ~~ 
H 
5-HYDROXYTRYFTOFHAN 
AROMATIC k-AMINO 
ACID 
D EX::ARBOX"YLAS E 
5 -HYDROXYTRYFTAMIN E 
(S EROTONIN) 
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pineal gland (fig. 8). serotonin can be oxidized to 5- hydroxyindole-
acetaldehyde by the enzyme monoamine oxidase (Axelrod et a l., 1969). 
A further oxidation leads to the formation of 5-hydroxyindoleacetic acid 
(Wurtman and Larin , 1968). This Can then be O-methylated in the 5 
position (as was the case with N- acetylserotonin) by HIOMT to form 
5-methoxyindoleacetic acid (Wurtman and Axelrod , 1967 ). 5-Hydroxy-
indoleacetic acid fo rmed from serotonin can alternatively be reduced 
t o 5-hydroxytrypt ophol and then converted to 5- methoxytryptophol by 
HIOMT (Wurtman and Axel rod , 1967 ; Wur tman et al. , 1967) . 
1.2. 3 The Receptors 
Once it had been established by Kappers (1960) that the pineal is heavily 
innervated by the sympathetic nervous system and that the pineal body 
contains high concentrations of noradrenaline (Wo l fe et al., 1962) as 
well as serotonin and histamine (Giarman and Day, 1959), the question arose 
whether the nor adr ener gic receptors in the pineal ;!ere alpha (a) or bet a (~) 
or both . To find out , organ culture systems were developed by Wurt_ 
man and Larin (1968 ); Klein et al., (1970b). Radioactive DL_[3_14CJ-
tryptophan was added to a pineal organ culture and the formation of 
radioactive serotonin , melatonin and 5-hydroxyindoleacetic acid moni tor ed . 
Addition of the catecholamine , L- noradrenaline greatl y enhances the 
synthesis of these t r yptophan derivatives . Propranolol, a ~-adrenergic 
blocking agent , prevents thi s increased synthesis , (Wurtman et a l . , 1971) 
--
whereas phenoxybenzamine , an a-adrenergi c blocking agent, does not. 
This observat i on indicated that the mechanism of stimulation invol ves 
'classic' ~-receptors. Other sympathomimetic amines such as tyramine, 
dopamine and octapamine also stimulate the formation of melatonin from 
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PINEAL Su;ONDARY INDOLE BIOSYNTHEIIC PATHWAY 
TO MELATONIN 
HO~CHrCHrNH2 
~N/ 
H 
5- HYDROXYTRYFTAMINE 
(SEROTONIN) 
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tryptophan , but to a lesser extent (Axelrod et al., 1969). The 
assumption that ~-adrenergic receptor stimul ation effects the synthesis 
of melatonin by acting on the cycl i c adenosine- 3 ', 5 '-monophosphate 
(cyclic AMP or cAMP) "second messenger " system was verified by adding 
dibutyryl cyclic AMP to a pineal organ culture. This compound Causes 
an increase in melatonin production (Klein et al. , 197Gb ; Wurt man et a l., 1971) . 
Stimulation of the ~-receptor activates the enzyme adenyl cyc lase 
(Br eckenridge , 1964) which in turn, catalyses the conversion of adenosine-
triphosphate (ATP) to cAMP (Robison et al., 1968a) . Cyclic AMP activates 
the enzyme serotonin N-acetyl transferase (SNAT) which ac etyl ates ser otonin 
to form N- acetylserotonin (Deguchi and Axelrod, 1972b; Deguchi , 
1972; Klein et a l., 197G b ). 
1. 2 . 3 .2 ~~~~~!~~~-~~-~~~~~!~~~!~-~~-!~~-~:~~~~~~~g~=-~~=~~!~~~ 
~~~~~=~~~!~~~!r_~~~_~~~=~~=~!~~~!r 
Deguchi and Axelrod (1973) found that t he res ponse of a pineal ~-adr energic 
receptor (or ~-adrenoceptor) to nervous stimulation depends on the previous 
exposure of the receptor to the neurotransmitter noradrenaline. When nor-
adrenaline, liberated from the nerve ending , is removed by denervat ion or 
reduced by reserpine administration , decentralisation , or continuous 
light i ng (which reduces sympathetic nervous stimulat ion as wil l be 
disGussed later), the response of cyclic AMP or serotonin N- acetyltransferase 
to stimul ation of the ~-receptor is greatl y enhanced. Conversely , if the 
number of catecholamine molecules reacting with the ~-adrenoceptor is 
increased for a period of time , the sensitivity of the receptor to its 
agonist is markedly reduc ed . (Larger amounts of catecholamine are then 
needed to elicit the same degree of increase in adenyl cyclase and SNAT 
activity compared with that exerted on ~-receptors that have not been 
previously exposed to catecholamine. 
- 18 -
The overall sensitivity of the ~-adrenoceptor varies diurnally as the 
amount of noradrenaline released by the sympathetic nerves varies during 
the course of a day (Romero and Axelrod, 1974) . Romero and Axel rod (1975) 
showed that al though ~ -adrenoc eptor supersensitivity increased the overall 
resul t ant activity of SNAT , there was a lag period prior to the induction 
of SNAT . Conversely, subsensitivity results in reduced SNAT act i vi ty, 
but the induction of the enzyme (SNAT ) is far more rapi d in onset . 
This phenomenon suggests the possibility that a precursor is necessary 
before fina l production of enzyme protein , and that ~-receptor stimulation 
is necessary to produce this precursor. 
Kebabian et a l. (1975) showed that ~ -receptor stimulation causes a 
rapid decrease in the number of specific sites which will bindJl - [3Hl -
alprenolol, thu s decreasing the sensitivity of adenyl cyclase to ~-
adrenergic stimul ation . Romero et a l. (197:a) f ound that t he number 
of [3HJ -alPrenolol binding si t es varies with a c ircadian periodicity 
inversel y related to t he rhythm of neurotransmitter release . Inhibi tion 
of this ~-receptor stimulation (by exposure to light f or example ) causes 
a rapi d increase in the number of spec ific binding si t es . This phenomenon 
Can be i nterpreted as being rel ated to an i ncrease or decrease in the 
number of ~-adrenergic receptors availabl e when the pineal gl and is 
subjected to nervous inhibition or stimulation respectively. This would 
explain the mechanism of supersensitivity and subsensitivity which occurs 
during the course of a day (fig . 9) . 
1. 2.4 Cyclic AMP and Its Influence on SNAT 
Cyclic adenosine-3 ', 5-monophosphate is now well established as the intra-
cellular mediator of the actions of a variety of substances that affect 
Fig. 9. 
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cell function following the interaction of a neurotransmitter with extra-
cellular receptors (Robison et al. , 1968b). In tbe pineal gland , release 
of noradrenaline at tbe nerve endings stimulates adenyl cyclase activity 
(Weiss and Costa, 1967) which converts ATP to cAMP (Shein and Wurtman , 
1969; Klein et al., 1970a; 1970b). Cyclic AMP , the "second messenger ", 
(Robison et al ., 1968~ increases SNAT activity (Deguchi, 1972) resulting 
in an increased formation of N-acetylserotonin and subsequent formation 
of melatonin (fig. 9). This can a l so take place in organ culture 
(Klein et al., 197Ob)or in vivo (Deguchi and Axelrod , 1972a) and can be 
-- ---
caused not only by catecholamines but by their precursor, k- Dopa as wel l. 
It seems that the control of mela tonin synthesis is at the serotonin 
N-acetyltransferase level. 
It has been shown that theophylline raises the int racell ular concentration 
of cyclic AMP (Kakiuchi and Rall , 1.968) by inhibiting the cyclic nucleotide 
phosphodiesterase (Butcher and Sutherland, 1962; Cheung , 1967), which 
converts cAMP t o adenosine monophosphate (AMP). Any exogenous cAMP 
added to a pineal organ culture is degraded by t he phosphodiesterase. 
To overcome such degradation , dibutyryl cyclic AMP (N 60 2'-dibu tyryl 
adenosine- 3 ', 5' - monophosphate), the diacyl ated derivative of cAMP , has 
been used instead as it is not a substrate for the enzyme. The addi tion 
of either noradrenaline (Axelrod et al., 1969) or dibut yryl cAMP (Shein 
--
and Wurtman, 1969; Klein et al. , 1970a) to organ cultures, stimulates 
the conversion of radiolabelled tryptophan and serotonin to melatonin. 
These compounds do so by mimicking the action of cAMP and stimulating 
SNAT activity (Klein et al ., 1970b) , which , as stated before , converts 
serotonin to N- ac etylserotonin (Weissbach and Axelrod, 1960; Berg and 
Klein , 1971). Accelerated enzymic formation of melatonin by simple 
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mass action (Klein and Rowe, 1970) and a net eflux of N-acetylserotonin 
and melatonin from the pineal cell results . When theophylline and 
dibutyryl cAMP are added to pineals that have already been stimulated 
by noradrenaline, no further stimulation of melatonin production is 
observed (Weiss and Costa , 1967; Kakiuchi and RaIl, 1968) which suggests 
that these three compounds are acting at the same site , and that this is 
already maximally stimulated. Lynch et al. (1977) showed that pineal 
SNAT activi ty is not only controlled by sympathetic nervous innervation 
controlling cAMP levels , but also by an adrenal effect; catecholamines 
rel eased from the adrenals stimulate SNAT activity. 
Berg and Klein (1971) showed also that actinomycin D and cycloheximide 
block the dibutyryl cAMP stimulation of [3H] - melatonin production from 
[3H] - tryptoPhan , a result which indicates that synthesis of new protein 
is needed. This was further substant i ated by Deguchi (1972). When 
he injected rats i.v. with isoprenaline, cAMP level increased 
immediately and fell to its initial level after 15 minutes. SNAT 
rose one hour after injection and returned to its initial level after 
5 h. However, prior treatment wi th propranol ol blocks an increase in 
SNAT activity. If propranolol is injected when SNAT activity i s at 
a maximum , the level of activity drops rapidly showing that maintenance 
of high SNAT levels requires continuous stimulation of the ~-adrenergic 
receptor of the pineal cell. When he gave cycloheximide before or after 
cAMP had dropped back to its normal level, there was no increase in SNAT 
activi ty. After SNAT activity had a lready increased, no rapid effect 
by cycloheximide was observed as new protein would by then already have 
been synthesized. Cyclic AMP seems to act on the translation process 
in the new enzyme molecules as actinomycin- D has no immediate effect on 
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the induction of SNAT (Deguchi and Axelrod, 1972a). The lag period 
before SNAT increases after exposure to light and the ~-stimulation 
appears to be due to a lack of messenger RNA which first has to be 
synthesized during this lag period (Zatz et a l., 1967). 
Cycloheximide actually Causes a slow fall in high SNAT activity. These 
findings indicate that there are two types of changes in SNAT activity: 
a rapid change mediated by the ~-receptor-second messenger system and 
a slow one which represents enzyme turnove~ and is dependent on enzyme 
protein synthesis (Deguchi and Axelrod , 1972b) . 
1. 2.5 Other Enzymes in the Pineal Indole Biosynthetic Pathway 
This is the enzyme which hydroxylates tryptophan in the 5-position. It 
has highest activity in the rat pineal gland (Lovenberg et a l., 1967). 
--
It has generally been accepted that hydroxylation of tryptophan by this 
enzyme is the rate-limiting step in serotonin (5- hydroxytryptamine) 
biosynthesis. 
This is a non-specific enzyme and is responsible f or the conversion of 
5-hydroxytryptophan to 5-hydroxytryptamine (serotonin). The pineal 
gland has the h ighest concentration of this enzyme of all mammalian 
tissues so far examined (Snyder and Axelrod , 1964b). The activity of 
pineal aromatic ~-amino acid decarboxylase is under sympathetic 
neural and photic control (Snyder e t al., 1964 b; Snyder et al. , 1965a). 
The enzyme can be assayed by a method described by Snyder and Axelrod (1964a). 
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Many enzymes occur i n pineal parenchymal cells (Tapp et al ., 1973), 
including glucose-6- phosphate dehydrogenase (Hess et al., 1958), succinate 
dehydrogenase (Nachlas et al. , 1957a) , lactate dehydrogenase (Hess et al., 
1958) , NAD diaphorase (Scarpelli et al., 1956) , cytochrome oxidase 
--
(Burns tone , 1961), monoamine oxidase (Glenner et al., 1957), non-specific 
esterase (Gomori, 1950), leucine amino peptidase (Nachl as et al., 1957b), 
--
acid phosphatase (Grogg and Pearse , 1952), and a lkaline phosphatase (Gomori , 
1951). Most of these , with the exception of a l kaline phosphatase, were 
found to be present in moderate to high levels. The presence of high 
levels of oxidative enzymes suggests a hi gh overall degree of metabolic 
activity in the pineal gland. 
Hydroxyindole-O-methyltransferase (HIOMT) catalyses the conversion of 
N-acetylserotonin to melatonin (N- acetyl-5-methoxytryptamine) by 
transferring a methyl group from S~adenosyl-1-methionine to the hydroxy 
group in position 5 on N- acetylserotonin (Axelrod and Weissbach, 1960). 
It has been shown that HIOMT from different animals differs in electro-
phoretic mobility on a starch block (Axelrod and Vesell , 1970) . The 
enzymes differ a lso in heat stability , Km values and substrate specificity. 
Jackson and Lovenberg (1971) establ ished that the molecular mass of HIOMT 
is about 76000 to 78000 and that is also exists in higher molecular maSs 
aggregates. It exists as two differently-charged subunits which can be 
separated. They also showed that in the pineal, HIOMT may be regarded 
as a major protein constituting about 4% of the so l uble protein in the 
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gland. Studies by Cardinali and Wurtman (1972) showed that HIOMI' is 
present in the rat retina and harderian gland. From their Km values 
and stability in s torage, these authors conclude that pineal and retinal 
HIOMT is very similar but that harderian HIOMI' is a different enzyme and 
that its physiological role may involve substrates other than indoles. 
Deguchi and Barchas (1971) showed that S-adenosylhomocysteine, to which 
S-adenosylmethionine is converted as a result of the transfer of a 
methyl group, is a potent inhibitor of the transmethylation process. 
This occurs because HIOMI' exhibits a much greater affinity for S-adeno-
sylhomocysteine than for S- adenosylmethionine . They a l so found that 
the supernatant fraction of brain homogenate contains an enzyme which 
stimulates transmethylation . Yang and Neff (1976) established that 
the diurnal variation in pineal HIOMI' activity is due to an alteration 
of enzyme mo l ecule numbers rather than a change in enzyme kinetics . 
1.2.6 Serotonin 
Serotonin, or 5- hydroxytryptamine , is present in the pineal gland and 
i ts sympatheti c nerve endings in large quantities (Quay, 1963) . The 
content of s erotonin in the pineal follows a 24- hour cycle. serotonin 
levels appear to be under the control of sympathetic nerves (Snyder et al. , 
1964b; 1965b) . Serotonin is synthesized according to the indole bio-
synthetic pathway (fig. 7). Tryptophan hydroxylase appears to be the 
rate-limiting enzyme in the biosynthesis of serotonin (Lovenberg et al. , 
1967) • Brownstein et al. (1973b) and Klein e t al. (1973) demonstrated 
-- --
that serotonin levels in the pineal appear to be regulated by the ~-
adrenergic receptor stimulation which controls serotonin N-acetyltransferase 
ac tivity . Serotonin in the pineal is me tabolized to melatonin and 5-
methoxyindole acetic acid. 
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1.2.7 Melatonin 
Melatonin is an indoleamine synthesized primarily in the pineal gland . 
As far back as 1917, it was shown that this substance (although not yet 
identified as melatonin) could cause blanching of the skin of repti l es 
and amphibians (McCord and Allen , 191 7). Today it is regarded as " the 
pineal hormone". Mel atonin and 5- methoxyindole- 3- acetic acid were isolated 
first from bovine pineal glands (Lerner et al. , 1960) . This finding 
demonstrated that hydroxyindoles could be O-methylated in the same way 
as catecholamines. Kopin et al. (1961) elucidated the metabolic pathway 
of melatonin in mice. They showed that labelled melatonin is rapidly 
metabolized after injection; the major pathway is by way of 6-hydroxy-
lation, followed by conjugation , mainly with sulphate (70%) and to a 
smal l extent with glucuronic acid (6%). A small portion remains tissue 
bound . Circulating melatonin is rapidly taken up by all tissues , 
including the brain. Anton-Tay and Wurtman (1969) showed that tritiated 
melatonin is concentrated in the brain after both intravenous and intra-
ventricular injection , a lthough with the latter route, the brain 
concentration is almost a hundred times higher. 
By using an organ culture technique , Axelrod et al., (1969) showed that 
--
noradrenal ine liberated from the sympathetic nerves , stimulates melatonin 
f ormation. 
1.2.8 Glycoproteins 
Lott et al. (1972) on incubating [3HJ - fucose with rat pineal glands, found 
that it was taken up, synthesized into [3H]-fucose-containing gl ycoproteins 
and released back into the medium. It has been suggested that these 
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glycoproteins could act as carrier proteins responsibl e for the transport 
of a hormonal substance like melatonin from the pineal parenchymal cells 
into the interstitial spaces prior to its release. 
1.2.9 Melatonin and Ehterochromaffin Cells 
Raikhlin et al. (1975) found melatonin in enterochromaffin cel l s of the 
human gastro-intestinal tract. They later showed that active biosynthesis 
of melatonin was actually taking place in these cells (Raikhlin and Kvetnoy, 
1976). They proposed that as the enterochromaffin cells and pinealocytes 
both produce melatonin , they could be grouped together as one functionally 
active neuroendocrine system. These two sources of melatonin, a lthough 
anatomically distinct may wel l be ful fill i ng the same role. 
1.3 PINEP.L PHYSIOLOGY 
1. 3. 1 Influence of Light on the Pineal 
The pineal gland exhibits a number of biosynthetic rhythms of varying 
duration. No other endocrine organ exhibits as many rhythms as the 
pineal. Some of these rhythms have periods of 24 hours, other of 7 days 
and others as long as one year (Reiter, 1976). Control of metabolic 
function in the pineal gland is mediated via the sympathetic nervous 
system. An increase in sympathetic stimulation increases the production 
of melatonin. When the sympathetic nerves to the pineal gland are cut, 
light no longer has an effect on melatonin synthesis (Wurtman et al. , 
1964c) • Brownstein and Heller (1968) reported that stimulat ion of the 
preganglionic fibres to the superior cervical ganglion decreases HIOMT 
activi ty. This is similar to the effect of light, suggesting that 
the photic inhibiting effect is mediated by autonomic innervation to 
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the pineal. In rats less than 12 days old (Zweig et al., 1966) there 
1S an extra-retinal pathway for l ight which influences the pineal gland . 
It is assumed that whi l e rats are still young, light can penetrate the 
skull and control physiological processes before visual function can be 
demonstrated. 
Exposure to light reduces the ability of the pineal gland to synthesize 
melatonin (Wurtman et al., 1964c) and also decreases the mass of the 
gland (Fiske et a l., 1960). Moore et a l. (1967) showed that the central 
visual pathway essential for mediation of this response is the inferior 
accessory optic tract (fig. 10). It was also shown t hat the effect of 
light on mel atonin synthesis was probably due to the marked change in 
HIOMT activity (Wurtman et al ., 1963b) when rats are pl aced in continuous 
darkness for 6 days , there is a large increase in the level of this 
enzyme . Exposure to constant light has the opposite effect , HIOMT 
activity being greatly reduced. These findings suggest that there is 
a naturally occuring diurnal rhythm in HIOMT activi ty and that this 
fluctuation caused by l ight is probably due to a change in the ra te of 
protein synthesis (Axelrod et al., 1965) . Taylor and Wilson (1970) 
provided elec t rophysiological evi dence for the action of light on the 
pineal by demonstrating that the spontaneous tonic level of pineal 
electrical activity is markedly reduced by photic stimulation. In an 
apparent contradiction of these f indings , it was shown that light i ncreases 
the concentration of cAMP in the pineal gland (Ebadi et al ., 1970) . It 
was suggested that this was due t o an increased synthesis of the cyclic 
nuc l eotide or that the endocrine system may be involved . Klein a nd 
Weller (1972) on the other hand found that l i ght acting via its 
established route, viz. retina , inferior accessory optic tract, median 
OPTIC NERVE 
OPTIC CHIASM---I 
OPTIC TRACT--r'1 ~7 
- 28 -
MEDIAL 
FOREBRAIN 
Fig. 10 . Central visual projections in the rat. 
and 
SAOT 
XOT, cr ossed compo~ent of primary optic tract; UXOT , uncr ossed 
component of primary optic tract; SAOT, s upe rior acc e ssory optic 
tract; RH, retino-hypothalamic fibres; IAOT, inferior accessory 
opt ic t ract; MTN , medial terminal nucleus (Moor e ~ al., 1968). 
- 29 -
forebrain bundle, superior cervical ganglion and nervi conarii causes 
the dark-induced ac t ivity of serotonin N- acetyltransferase to decrease 
very rapidly (Heller and Moore , 1965; Axelrod and Snyder , 1966) . 
phenomenon could involve simple inhibition of adrenergic neuronal 
stimulation. Alternative hypotheses could include: (i) the non-
This 
adrenergic neural transmission of a visual signal (ii) the release of 
a second transmitter from nerve endings in response to a net uptake of 
noradrenaline , which woul d occur at the termination of the dark- induced 
noradrenaline release , (iii) electrochemical changes in the pinealocyte 
processes which could be associated with termination of neural stimulation. 
The overall effect of light on the rat pineal therefore is one of metabolic 
inhibi tion . The circadian fluctuation in this inhibitory input is largely 
responsible for the presence of various biorhythms in the pineal gland. 
Brownstein and Axelrod (1974) demonstrated the existence of a 24- hour 
rhythm in the turnover of noradrenaline in the sympathetic nerves 
innervating the rat pineal gland. By measuring the ra t e of di sappearance of 
[3Hl-noradrenaline from the pineal over the course of a da~ they found 
that the turnover of this catecholamine is more than twice as rapi d during 
the night than during the day. They established also that the rhyth m is 
endogenous as it persists in b l inded animals . In normal animals, exposure 
to l ight during the night causes a marked reduction in the rate of nor-
adrenal ine turnover. The aut hors conclude that the 24-hour rhythm in 
noradrenaline turnover probably reflects diurna l variations in the 
release of the neurotransmitter. By extension, it was also concluded 
that the daily variation in pineal ~-adrenergic receptor stimulation is 
probably responsible for the circadian rhythms in the metabolism of 
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pineal indoleamines (serotonin , N-acetylserotonin etc.). The fluctuation 
in noradrenaline is most certainly responsible for a daily rhythm in adenyl 
cyclase activity , cyclic AMP concentration and , consequently, serotonin 
N-acetyltransferase (SNAT) activity. Klein et al . (1971) found that 
superior cervical sympathectomy abolished the rhythm in SNAT activity , 
strongly suggesting that sympathetic innervation and noradrenaline 
release control SNAT levels. It could also be assumed that there is 
no sympathetic or photic control over tryptophan hydroxylase , as it 
exhibits no circadian rhythm (Deguchi and Barchas , 1972). 
Pineal serotonin content has been shown to exhibit a circadian rhythm 
(Quay, 1963) under sympathetic nervous control (Fiske, 1964 ) . This 
rhythm ranges from about 10 ng/pineal at the nocturnal minimum to over 
90 ng/pineal at the midday maximum . There is a rapid decrease in 
serotonin content at the onset of darkness, the level falling at a rate 
of about 25 ng/hour . From midnight to midday , there is a gradual 
increase of about 6 ng/hour . 
Snyder et a l. ( 1965b) demonstrated that constant light abolishes circadian 
--
changes in pineal serotonin content whereas the rhythm persists in rats 
kept in constant darkness . Disruption of the sympathetic nerve supply 
abolishes the rhythm , but blinding does not. These facts su ggest that 
the pineal circadian serotonin rhythm is endogenous , but is cued or 
regulated via the sympathetic nerve supply by an ext ernal synchroniz er. 
(Thi s coul d be feeding or any other sympathetically controlled event.) 
The serotonin rhythm appears to depend on alterations in the rate at 
which serotonin is released from intracellular binding sites (Snyder and 
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Axelrod , 1965). During the day , the amine is bound (within parenchymal 
cel ls or sympathetic nerve endings) in such a manner as to make it 
unavailable for conversion to melatonin or destruction by monoamine 
oxidase. The onset of darkness seems to trigger the release of bound 
serotonin. 
serotonin rhythmicity can be ascribed to two main factors , both influenced 
by light : (1) Snyder et al . ( 1964a) showed that exposure of rats to 
constant light causes a marked increase in aromatic-L- amino acid 
decarboxylase activity , the serotonin-forming enzyme (Snyder and 
Axelrod , 1964a ) when compared with its levels in rats kept in constant 
darkness. This enzyme thus exhibits a circadian rhythm which is under 
photic influence , peaking in the day and declining at night in parallel 
with the serotonin rhythm. Snyder et al . (1965a) showed a l so that 
aromatic-1 - amino acid decarboxylase activity is controlled by the 
sympathetic nervous system. When rats are subjected to superior 
cervical ganglionectomy , the light-induced rise in enzyme activity is 
prevented. (2) Brownstein et al. (1973a) found that the· enzyme SNAT 
shows a diurnal rhythm as well , which is 1800 out of phase with the 
rhythms of serotonin and aromatic - k-amino acid decarboxylase . SNAT 
activity is more than 15 times higher at night than during the day . 
This circadian rhythm persists in complete darkness or in blinded 
animals and is suppressed in constant lighting (Klein and Well er, 1970a). 
The circadian rhythm in SNAT activity appears 4 days after birth in rats 
and develops most rapidly over a 7-day period one week after bir th. A 
concomitant development in sympa thetic nervous innervat ion and in t he 
adenyl cyclase system probably accounts in part for the development of 
this rhythm (Ellison et al. , 1972). 
--
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When rats are exposed to light during the dark phase, SNAT activity, 
which peaks at night, declines rapidly . This is probably due to the 
inhibi tory effect of light on sympathetic nervous stimulation which is 
responsibl e for inducing SNAT activity in the first place. The degree 
of pineal SNAT suppression by light depends on its intensity. As little 
2 
as 0,5 mcW/cm causes more than 50% suppression of the enzyme and maximwn 
inhibition has been observed with .15 mcw/cm2 light intensity (Minneman 
et al., 1974) . It is the rhythmic fluctuations of the serotonin-forming 
enzyme,aromatic-1-amino acid decarboxylas~and of the enzyme which converts 
serotonin to N-acetylserotonin,i.e. SNAT, which are responsible for the 
circadian rhythm shown by serotonin in the pineal gland. 
As a consequence of the SNAT rhythm, the product of N-acetylation, i.e. 
N-acetylserotonin, shows a diurnal rhythm in phase with that of SNAT. 
It exhibits a nocturnal peak and a diurnal trough. If rats are 
exposed to light dur ing .the night , the level of N-acetylserotonin falls 
rapidly due to the light-induced decline of SNAT (Brownstein et al., 1973a). 
HI OMT activi ty undergoes a 24-hour cyclic fluctuation peaking at night 
and dropping during the day (Axelrod et al., 1965). This rhythm is 
also controlled by light (Wurtman et al., 1963b) which suppresses the 
activity of the enzyme. Cardinali et al. (1972) investigated the 
relationship between various light source spectra and HIOMT activity. 
When rats are exposed to green , blue or yellow light after 7 days of 
darkness, time- rel ated decreases in pineal HIOJ1I' activi ty are observed. 
Green light has the most pronounced effect in decreasing enzyme activity. 
Red l ight has no effect. Cool wh i te fluorescent tubes have been shown 
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to be more effective than "vita-lite" sunlight-simulating sources in 
decreasing HIOMT activity. (Fig. 11a). 
Wallen and Yochim (1974a) found that the level of enzyme activity in 
female rats also depends on the stage of the rat oestrous cycle . The 
enzyme activity is highest during metoestrous and dioestrous and lowest 
during oestrous. The irregular fluctuation of HIOMT was ascribed to 
the existence of two component rhythms of different frequencies. The 
interaction of these rhythms creates a "beat frequency " oscillation. 
If rats are placed in continuous dark , HIOMT activity rises and remains 
at a high level (Wurtman and Axelrod, 1965), but an "oestrous cycle" 
pattern of HIOMT activity still remains (Yochim and Wallen, 1974a). 
Continuous light completely abolishes HIOMT rhythm. Al though HIOMT 
rhythm appears to be externally regulated and almost entirely dependent 
on shifts in environmental lighting (therefore suggesting that this 
enzyme rhythm may be more important in carrying information about light 
than other circadian rhythms that do not depend on light for their 
existence) , the presence of a rhythm in the dark varying wi th oestrous 
cycle demonstrates an endogenous aspect of the rhythm. Three important 
factors have thus emerged from the stUdies (Yochim and Wallen, 1974a) of 
constant conditions on HIOMT rhythms : (1) an endogenous pattern of HIOMT 
activity exists in constant darkness with smaller amplitudes and a 
decreased rate of activity ; (2) both theoretical rhythm components 
of the HIOMT pattern are endogenous ; (3) constant light gradual ly 
aboli shes rhythmici ty and causes the acti vi ty of HIOMT to decrease 
wi th time. In terms of Wal l en and Yochim ' s mixed- wave hypothesis (1974a), 
all effects can be accounted for simply by changes in the numerical values 
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of the non-periodic terms of the mixed- wave equation. It can therefore 
be assumed that HIOMT activity varies seasonally and, as a result, can 
modify basal release of gonadotrophins . This is due to the anti -
gonadotrophic action of mel atonin which will be discussed . 
As HIOMT, which has a circadian rhythm, is responsibl e for converting 
N- acetylserotonin to melatonin , it can be assumed that mel atoni n under-
goes a diurnal fluctuation as well, which is in phase with the HIOMT 
rhythm. This happens to be the case. It undergoes a 24-hour rhythm, 
attaining a maximum peak a t night and dropping to a low level during 
the day. Lynch et al . ( 1975) collected melatonin from human volunteers 
and concentrated it on an Amberlite XAD- 2 resin column. By using a 
bioassay technique, they showed that the amount of melatonin from urine 
samples collected between 23hOO and 07hOO Was several times higher than 
that of samples collected between 07hOO and 15hOO or 15hOO and 23hOO. 
This not only confirms that melatonin is released in a rhythmic fashion , 
but a l so that at l east some melatonin in human beings finds its way 
chemically unchanged into the urine. Hedlund et al. (1977) , using a 
radioimmunoassay technique , showed that the l evel of mel atonin in the 
cerebrospinal fluid of calves increases 17-fol d at n i ght in comparison 
with daytime levels. Plasma concentrati ons increased approximately 
6- fold. (Fig. 11b). 
1. 3 . 2 Other Effects of Light 
1. 3 . 2 .1 Pineal Gonadal Function 
Besides the direct effec ts of l ight on the pineal gland (in inhibiting 
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HIOMT activity for example) studies have shown seconda.ry manifestations 
of light effects. Light may affect other organs indirectly owing to an 
effect on the pineal gland, or due to a direct effect. In the latter 
case, it is possible that some retinal target- organ neuronal pathway 
exists which allows light to have some modulating influence on that 
particular organ, or light may impinge directly on some area of the brain. 
Lisk and Kannwischer (1964) for example found that light a pparently has a 
direct ef fect on the suprachiasmatic nuclei of rats . They allowed light 
to impinge on thi s area by way of glass r ods through the skull and thus 
demonstrated a significant increase in the incidence of vaginal oestrous. 
Fiske (1939) also has found that rat pituitary gonadotrophin levels vary 
according to a lighting schedule. This variation is most likely due to 
a pineal-mediated effect, but it is conceivable that the changes may be 
directly mediated. 3 Wurtman et al . (1964b) found that [ HJ-melatonin 
was highly concentrated by the pineal, iris-choroid and ovary as well as 
other endocrine organs and peripheral and sympathetic nerves. Constant 
exposure to light was shown to dimini sh the uptake of melatonin by the 
ovary. This may be another way in which light affects the oestrous 
cycle . Constant light enhances the incidence of vaginal oestrous in 
mature rats, whereas darkness has the opposite effect (Wurtman et aI. , 
1964a) . Interruption of the photic pathway by blinding or by superior 
cervical ganglionectomy blocks these l ight effect s and prevents light-
induced hypertrophy of the ovari es . Hoffmann (1967) found that rats 
deprived of light by blinding or by being kept in constant darkness at 
the age of 21 days continued their oestrous cycles regularly for 8 months, 
while animals deprived of light at the age of about 90 days began to show 
prolonged cycles and in some cases ceased after 3 months . It appears 
that if cycles begin in the absence of light, they can continue fai rly 
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normally, but if they commence in the presence of l ight, their continuance 
is dependent on light, and deprivation of light in this case has profound 
effects on most rats within 3 months . Light therefore appears to be 
necessary for the normal functioning of the pituitary-ovarian axis. 
In another report Hoffmann (1973) discusses the poss ible effects of earl y 
lighting on oestrous cycles in rats. Most rats which had been born and 
raised in constant light, if then blinded or exposed to light/dark of 
12h/12h, had predominantly 4-day oestrous cycle lengths. If the light/ 
dark ratio was changed to 16h/8h , these rats tended to show a 5-day cycle. 
Rats born and raised under a diurnal light/dark regimen of 12h/12h also 
showed 4- day cycl es after blinding , bu t if kept In a 12h/12h or 16h/8h 
photoperiod, they showed mainly 5- day cycles. It seems that both 
environmental and genetic factors playa part in responses which the 
female r at reproductive system manifests to light in adulthood . Early 
constant lighting also seems to render a f~male rat less s ensitive to 
dark. However, genetic differences among rats seem to determine 
inherent length of cycl e a nd to affect rep roductive responses to light 
deprivation. 
Lawton and Schwartz (1967) studied the effects of constant light on 
gonadal-adenohypophyseal- hypothalamic function in rats. They found 
constant light led to a desynchronization of 24-hour rhythms . A state 
of persistent oestrous eventually devel oped which was char acterised by 
a fa i lure to release a surge of LH necessary for ovulation. A steady 
state of ovarian steroid release also developed. It was possible to 
divide persistent oestrous into two stages, which depended on the number 
of days the rats had been exposed to constant light before persistent 
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oestrous developed. The first group, which had been in constant light 
for 60 days or less, showed prolonged vaginal cornification which was 
interrupted occasionally by ovulation. Pituitary LH level was high. 
The second group, which had been in constant light for more than 60 days, 
had prolonged vaginal cornification, no breakthrough ovulation and low 
pituitary LH content. It seems likely that reproductive cyclicity 
depends on the synchronization of various rhythms within the hypothalamo-
hypophyseal-ovarian axis, which in turn is dependen t on an alternating 
light-dark rhythm. It has been noted however (Brown-Grant et al., 1973), 
that ovulation in rats exposed to constant light may be induced by mating, 
penile intromission being responsible for its occurrence. 
Wallen and Yochim (1974c) exposed female rats to a 20-hour day in an 
attempt to modify their oestrous cycles predictabl y. Their results 
indicate that the function of the pineal gland appears to be related 
primarily to regulating the duration of the degree of activi ty of the 
hypothalamic-pituitary-ovarian axis, which is functionally essential 
to the oestrous cycle. In another report, they proposed that HIOMT 
activity, and in turn vaginal oestrous cyclicity, are governed by the 
interaction of two rhythms, one of which although endogenous, is cued 
by photoperiod (Yochim and Wallen, 1974c). They found that under phase 
conditions in which maximal amplitudes of HIOMT activity were generated, 
the incidence of vaginal cornification and persistent oestrous, which 
are indicators of oestrogen secretion, was high and vice versa. These 
results offer strong support for the concept that a photoperiodic rhythm 
affects both pineal HIOMT a~d aspects of reproductive function identically. 
(Fig. 12) . 
Fig. 1 2 . 
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Continuous i llumination suppresses water intake of male and female rats 
(Zucker , 1971). Bilateral transection of the inferior accessory optic 
tracts compl etel y abolishes this effect, suggesting th2t t bese tracts 
form part of the principal visual pathway by which excessive light 
exposure depresses drinking (Stephan and Zucker , 1972) . Constant 
light exposure was found also to cause hypertrophy in neurosecretory 
cells of the supra- optic nucleus , indicat ing increased antidiuretic 
hormone (ADH) synthesis and release. This response appears to be a 
direct effect of light rather than being a consequence of reduced water 
intake. The effect of light on drinking seems to be independent of 
pineal and gonadal changes as the suppression of water intake was seen 
to exist in both pinealectomised males and ovariectomised females. It 
is possible that direct retino-hypothalamic innervation of neurosecretory 
c ells which are involved 1n t his suppressive effect of light , may exist. 
Spencer et al. (1976) established the existence of a 24-hour bimodal 
--
rhythm in femal e ra t core tempera ture . By shifting t he phase of the 
photoperiod , or altering the proportion of l ight per day , they showed 
that the rhythm is entrained by l ight but that the two component peaks 
are controlled by different aspects of the lighting regimen. The 
primary rhythm seems to be endogenous , entrained only by a circadian 
photoperiod , whereas the secondary rhythm is exogenous, requiring a 
circadian light-dark rhyt hm . The relationship between mean core 
temperature and the proportion of daily li ght was drastically alt ered 
by pinealectomy , but no effect on rhythmici ty was observed . This 
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suggests that the pineal regulates a light-dark dependent set point 
about which oscillations in core temperature may be generated . 
1.3 . 2 . 4 Growth 
Relkin (1972) reported that constant darkness r educed the production and 
r e l ease of growth hormone (GH) by the pituitary with consequent growth 
reta rda tion • This effect is probably exer ted by increased pineal 
secretion which inhibits growth hormone rel easi ' :g factor (GHRF) release 
f .rom the hypotha l amus . 
1. 4 INFLUENCE OF MELATONIN AND OTHER PINEAL ANTI GONADOTROPHINS ON 
ENDOCRINE ORGANS 
1.4 .1 The Hypothalamic-Hypophyseal Axis 
1.4 .1. 1 LH and FSH 
The antigonadotrophic action of t he pineal gland is now an established 
fact. However, because pinealectomy does not necessari ly have a 
pronounced effect on gonadotrophic function in most species, it may be 
assumed that the role of the pineal here is as a modula t ing i nfluenc e 
on overall reproductive function. 
The firs t conclu sive evi dence of pineal inhibition of gonadotrophic 
func tion was obtained by pinealectomising seasonal breeders such as the 
hams t er (Hoffmann and Reiter , 1965 ). This opera tion resulted in marked 
alteration i n gonadal mass. Wurtman et a l. (1963a) hav e demonstrated 
that melatonin administered to female rats causes a significant reduction 
in the number of positive oestrous vaginal smears. They gave immature 
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female rats intraperitoneal (i.p.) injections of melatonin, which also 
resulted in delayed vaginal opening and a large redt'.ction in ovarian 
mass. In addition, they found that tritiated melatonin was taken up 
largely by the ovary and pineal gland, suggesting a direct effect on 
the ovary. Constant lighting, which normally has an inhibitory effect 
on pineal function, was found to reduce this effect. 
McIsaac et al . (1964) showed however that 5-methoxytryptophol, another 
methoxyindole, had an even more pronounced effect in reducing the 
frequency of posi ti ve oestrous smears. In addition, ovarian masses 
in the 5-methoxytryptophol-treated rats were significantly less than 
control or melatonin-treated groups . Although its physiological effects 
seem similar to those of melatonin, in several instances it has been 
shown to be significantly more potent than melatonin in inhibiting the 
growth of the sexual organs . It is capabl e of blocking the rapid rise 
in plasma FSH after castration in adult male rats (Talbot and Reiter , 
197 3-1974). It has been concluded that this indole specifically 
inhibits FSH (Fraschini and Martini, 1970). 
Chu et al. (1964) confirmed the inhibitory effect of melatonin on the 
oestrous phase of the rat oestrous cycle and showed that this effect 
was not exhibited by the precursors of melatonin, i.e. serotonin or 
N-acetyl serotonin , or the major metabolite of me l atonin, 6-hydroxy-
melatonin. Soffer et al. (1965) found that defatted bovine pineal 
extracts exhibited a gonadotrophin-inhibiting activity when administered 
to prepuberal HCG-treated female mice. On the other hand Schnitman and 
Debeljuk (1971), using an aqueous defatted extract of human pineal gl ands , 
were unabl e to detect any inhibition of the HCG-induced increase of 
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uterine mass of young Wi star rats. This failure could well have been 
because accepted anti gonadotrophins such as melatonin are fat soluble 
and therefore would not have been present in this extract. I t is a lso 
possible that deg radation of pineal principl es took pl ace post mortem . 
Hoffman and Reiter (1965) have shown that pinealectomy stimulates 
gonadotrophin secretion. The question arose whether these anti -
gonadotrophic effects occurred as a result of direct pineal act ion on 
the reproductive organs, or whether the hypotha l amo- hypophyseal complex 
was implicated . Fraschini et al . (1968a; 1968b) found that when various 
pineal indole compounds, e . g . 5-hydroxytryptophol , melatonin and 5-
methoxytryptophol were implanted in the median eminence or midbrain of 
the rat, pituitary stores of the gonadotrophin, LH , were significantly 
reduced. This result not onl y suggests that the pineal gl and may 
exert its antigonadotrophic influence via the pituitary gland, but also 
that the brain has indole-sensitive receptors which may be implicat ed in 
the synthesis and release of LH from the pituitary gland. By what route 
the indoles reach these areas of t he brain remains still to be conclusively 
established. Fraschini and Martini (1970) also showed that by removing 
the pineal gland from young adult male rats , a conspicuous and highly 
significant enhancement of pituitary LH content resulted. Adams et al. 
(1965) have shown however that melatonin admi nistration increased 
pituitary LH content, which could mean that LH rel ease was inhibited. 
Hipkin (1970) reaffirmed the antigonadotrophic potential of the pineal 
gland after injecting pineal extracts into mice . These ext racts blocked 
the human chorionic gonadotroophin (HCG) and pregnant mares serum 
gonadotrophin (PMSG) - induced increases in uterine mass. He pointed 
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out that this effect could, however , also have been due to toxicity of 
the injected material. Cheesman and Forsha m (1974) have suggested 
that the effects in this case may be due to a direct breakdown of HeG 
or PMSG by pineal indoles. Systemically administered melatonin has 
been shown to affect the adrena l s, ovaries, uter us and pituitary. 
However, de Prospo and Hurley (1971) were unable to detect any effects 
on these organs when melatonin was administered intraventricularly. 
Kamberi et al. (1970), using an anterior pituitary perfusion technique, 
found that LH release by indoleamines such as melatonin and serotonin 
was not caused by a direct action on the anterior pituitary. They 
infused melatonin (2 pg/min for 30 min) into the stal k portal v essel, 
which drains into the sinusoids of the anterior pi tui tary. No di rect 
effect on peripheral serum LH concentration was noticed. However, 
melatonin injected intraventricularly caused a marked decrease in serum 
LH concentration. Thi s seems to indicate that melatonin acts indirectly 
via the hypothalamic-hypophyseal complex. 
Several investigators have reported that melatonin has an inhibi tory 
effect on reproduction. Collu et al. (1971), by implanting a cannula 
into a lateral ventricle, showed that melatonin could indeed inhibit 
ovulation in the rat when administered by this route. Subcutaneous 
administration of melatonin had no effect. They proposed that this 
finding was possibly due to inhibition of LH secretion. It has also 
been suggested that as melatonin has a central hypnotic effect, it may 
block ovulation in a manner similar to that of the barbiturates. 
Other possibilities are inhibition of ACTH release or an increase in 
brain serotonin levels. 
- 45 -
Moszkowska et al. (1973) showed that serotonin inhibits the synthesis 
and release of hypothalamic releasing factors i.e. FSH-releasing factor 
(FSH-RF) in vitro. This effect was noted after in vivo administration 
of serotonin into the third ventricle as well. This finding reinforces 
the suggested mode of action proposed by Kamberi et al. (1970). It has 
been found that chronic administration of serotonin can cause ovarian 
atrophy (Kamberi et a l., 1971). This is probably due t o inhibition of 
the release of FSH-RF and LH-releasing factor (LH-RF). Melatonin 
however, seems only to modify the synthesis of FSH-RF in synergy with 
serotonin or by an increase in cerebral serotonin levels. 
Other evidence implicating the pineal gland i n the control of FSH was 
suggested by Debeljuk et a l. (1970) who found that daily injections of 
300 Mg of mel atonin from day 21 to day 51 of age caused a sUbstantial 
necrease in the pituitary FSH content of male rats. Testicular 
retardation was a lso observed. Fraschini and Martini (1970) have 
maintained that 5-methoxytryptophol and serotonin are responsible for 
the antagonistic action of the pjneal on accumulation of FSH within 
the pi tui tary. When the pineal is removed, there is a three-fold rise 
in pituitary FSH ccntent. They regard these two indoles as being 
exclusive to FSH control and melatonin and 5-hydroxytroptophol as being 
the indoles concerned with the regulation of LH (Fraschini, 1969). 
Kambe.ri et al. (1970) however demonstrated that melatonin seems to control 
FSH secretion by an effect on a hypothalamic releasing factor. 
Martin and Klein (1976), demonstrated that physiologic concentrations 
of melatonin could directly inhibit the LH-RF-induced release of LH 
from the cultured pituitary gland of the rat. Other related indo leamines, 
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i.e. N-acetylserotonin and 5-methoxytryptamine , had no effect. Although 
Kamberi et al. (1970) were unable to demonstrate a direct effect by 
melatonin on the pituitary, it was concluded that melatonin acts both 
directly on the pituitary and indirectly on the hypothalamus to suppress 
the release of LH into the systemic circulation. 
Using pituitary glands in an organ culture, Martin et al. (1977) blocked 
LH-RF-induced release of LH' with melatonin . They also found that 
sero t onin and 5-methoxytryptamine were able to suppress LH release 
from the pituitary. It seems possible that melatonin, serotonin and 
5-methoxytryptamine react with a specific receptor on the pituitary to 
elicit their effect. The inability of Kamberi et al. (1970) to 
--
demonstrate a direct inhibitory effect on the pituitary may be ascribed 
to their use of adult rats while Martin et al. used neonatal ones . 
- -
Another important fac tor which may account for this difference in 
experimental results is that Kamberi measured basal LH levels, whereas 
Martin et al., measured LH-RF-induced l evels. 
Moszkowska et al. (1971) , using chromatographic separation techniques, 
established that two different types of pineal fac tors seemed to account 
for the antigonadotrophic activity of the pineal gland. A purified 
fraction (F3 ) with a molecular mass of about 700 was assumed to act 
directly on the pi tui tary to antagoniz e the rel ease of gonadotrophic 
hormones particularly FSH, in vitro. This fraction was considered to 
be free of melatonin and 5-methoxytryptophol. The other fraction of 
indoleaminergic material (F2), acts at hypothalamic level to regulate 
LH secretion. The exact role of the pineal gland in controlling 
gonadotrophin secretion was further clouded by results indicating 
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that subcutaneous implants of melatonin reversed the anti gonadotrophic 
effects of smell and sight deprivation (which cause a decrease in 
pituitary LH and prolactin)(Reiter et al., 1975). In other words, it 
exhibited a counter-anti gonadotrophic effect. The effect of melatonin 
here may be due to an inhibitory effect on the synthesis or release of 
primary pineal antigonadotrophins. It is also possible that melatonin 
renders the neuroendocrine axis insensitive to inhibition by the pineal 
hormones, direc tly stimulates the peripheral end organs, e.g. gonads , 
or increases the sensitivity of the end organs to circulating gonadotrophins. 
Melatonin may even stimulate the release of a progonadotrophic substance 
from the pineal gland or another or gan. It is a l so possible that the 
effects of melatonin may depend on the time of day when it is administered. 
In this connection Fiske and Huppert (1968) reported that a melatonin 
injection during hour 8 of the light period suppressed the normal rhythm 
in pineal serotonin , but when given after onset of darknes" no such 
effect WaS seen. 
In pursuance of the possibility that the function of the pineal gland 
may not necessarily be an anti gonadotrophic ene, Kao and Weisz (1977) 
incubated medial-basal hypothalami of rats and showed that melatonin 
could release a gonadotrophin-rel easing hormone (Gn-RH). Other 
puta ti ve neurotransmi tters had no effect. These facts seem to confl ict 
with the view that melatonin bas an inhibitory effect on gonadotrophin 
release, be it through a direct or indirect mechanism. 
The findings of White et al. (1974) reinforced this current line of 
pineal progonadotrophic research. They found unusual l y large quantities 
of Gn-RH , which is normally liberated from the hypothalamus, and 
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thyrotrophin--releasing hormone (TRH) p ""sent in the pineal gland of the 
rat. In fact, the pineal glands contained 4 to 10 times as much Gn-RH 
as the hypothalami of the same species. Furthermore, these pineal 
extracts were shown to be capable of inducing ovulation. TRH content 
was found to be of the same oreer as that of the hypothalami of the 
same species. It seems as though the pineal gland may be a supplementary 
source of these two releasing factors. They may exert a maintenance or 
tonic effect on the pi tui tary, or alternatively act on extra-pi tui tary 
areas in the brz in" 
Smythe and Lazarus (1973b) proposed that melatonin and serotonin play 
an important role in the regulation of growth hormone (GH) release from 
the pituitary gland. Previous researcher s had shown that pineal 
inhibition , by a tumour for example, encouraged growth (Kitayand 
Altschule, 1954) whereas pineal stimulation caused by darkness led to 
the opposite effect (Wurtman et al., 1968 ; Sorrentino et al., 1972). 
It seems therefore that conditions favouring high melatonin production 
result in retarded growth. It had already been shown that ser otonin 
enhances GH release (Collu et al., 1972), and Smythe and Lazarus (1973b) 
demonstrate" that both melatoni n and serotonin have antagonistic effects 
on GH release. They did so by administering melatonin and the ser otonin 
precur·sor, 5-hydroxytryptophan to rats and assaying blood samples for GH 
content. Melatonin greatly reduced the GH levels, whereas 5-hydroxy-
tryptophan increased it, suggesting that melatonin can block the GH 
response to serotonin. It seems that, in this case, melato,dn can 
act as a competitive blocker of serotonin receptors at the hypothalamic 
level. 
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On further investigation , Smythe and Lazarus (1974) found that, contrary 
to expectatio~s, oral acmini stration of melatonin to human male subjects 
e levated serum GH . Th"y postulated that this phenomenon cOt:.ld be du e 
to an interaction with hypothalamic receptor sites mediating the release 
of GH from the pituitary . The fact t hat other work by these two 
investigators has shown an inhibitory effect by me l atonin on GH re l ease 
could be a dose related effect due to mela tonin inhibition of GH release 
at a l ow dose and stimulation at a higher dose (Smythe and Lazarus, 1973a; 
1973b). 
1.4.1.3 Prolactin 
Not many studi es have been conducted on pineal-prolactin interrelation-
ships. It has been shown however that blind rats are deficient in mi l k 
and prolactin produc tion , phenomena which could be cue to an activa t ed 
pineal gl and (Reiter , 1972). Nir et al. (1968) found that pineal ectomy 
resul ted in a 13% decline in milk yield duri ng the second half of the 
nursing period. Kamberi et a1. (1 971) reported a correl ation between 
pineal activity and prol actin release. After injecting melatonin , 
either into the cerebral ventricles or a cannulated portal vessel, 
prolacti n l evels were measured . Following intraventricular administration 
of melatonin , it wa s found that the indol eamine suppressed the discharge of 
prolactin inhibiting fac t or, t hereby increasing prolactin l evels in the 
blood. Lu and Mei tes (1973) found that Lv. administration of 5-hydroxy-
t ryptophan significantly increased serum prolactin levels in rats, whereas 
serotonin gi ven intraveYlously had no significant effect. Melatonin a l so 
increased serum p~'olactin significantly. Serotonin has been shown not 
to stimulate pi tui tary r el ease of prolactin (Talwalker et aI. , 1963), 
but it is possibl e that 5-hydroxytryptophan or melatonin may do so. 
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It is also possible that 5-hydroxytryptophan and melatonin may stimulate 
the release of "prolactin releasing factor" from the hypothalamus into 
the systemic circulation. 
Although the pineal gl and is obviously of importance in prolactin 
release and mi l k production, more research is needed to elucidate its 
exact involvement. 
1.4.2 The Adrena l Glands 
Since Farrell (1959) described a pineal substance , glomerulotrophin , 
which specifically stimUlates aldosterone production by the adrenals, 
studies have been conducted in an attempt to clarify the possibl e 
relationship between the pineal gland and adrenal s . Farrell also 
postulated the existence of a second pineal factor, possibly melatonin, 
capable of inhibi ting adrenal steroidogenesi s (Farrell , 1960). Ogle 
and Kitay (1977) injected melatonin (50 ~g i . p.) daily into ovariectomised 
and hypophysectomised rats and found that it stimulates adrenal 5 0/-
reductase activity. It was therefore suggested that melatonin could 
be a potential contributor to the physiologic regulation of adrenal 
steroidogenesis. Farrell (1964) later indicated that the supposed 
glomerulotrophin was present in insignificant amounts. Wurtman et a1. 
(1959) found that pinealectomy increased adrena l mass in female rats, 
whereas a protein-free pineal extract retarded adrenal growth. Lommer 
(1966) repo.rted that a pineal extract inhibits adrenal ~-hydroxylase 
activity, which blocks the synthesis of aldosterone , cortisol and 
c ortisone. Jouan and Samperez (1964) postulated that serotonin, a 
hormone widely present in the central nervous system , and especially 
in pineal extracts t is responsibl e for al(los terone-releasing activity. 
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Gromova et al. (1967) demo~strated that melatonin inhibits a l dosterone 
production in vi t ro. HYFopl:ysectomy abolishes the inhibitory effect of 
melatonin on aldosterone production . Narang et al. (1967) in agreement 
with Gromova, found that mel atonin increases adrenal mass in f~ale rats. 
There are insufficient data at present to define a specific role of the 
pineal gland in modifying overall adrena l gland function , glucocorticoid 
and mineralocorticoid activity. 
1.4. 3 The Thyrcid Gland 
Not much is known at present about the relat ionship between t he pinea l 
gland and thyroid function. Scepovic (1963) has shown that pinealectomy 
131 
causes t hyroid hypertrophy and an increase in I uptake. It seems 
also to increase thyroid hormone secretions (Ishibashi et al., 1966), 
but does not modify the thyroid hypert rophy induced by propylthiouracil 
administration (Yamada, 1961) . Melatonin given subcutaneously to the 
131 
rat has been shoWY, to reduce thyroi d mass as well as I uptake 
(Baschieri et al., 1963) . It was assumed that this could be due to 
an inhibitory effect of melatonin on TSH or on the action of this hormone 
on the thyroid gland. Thi~blot et al. ( 1966) found that, in contrast , 
melatonin given to prepuberal rats produced marked hypertrophy of the 
thyroid gland. Mess (1969), however , was unabl e to show any effect of 
pinealectomy on t he gland. 
Panda and Turner (1968) demonstrat ed a goitrogenic effect of melatonin. 
It caused plasma thyroid stimulating hormone (TSH) level as well as thyroid 
size to increase . A similar effect would have been obtained by 
thyroidectomy. This finding seems to SUbstantiate the view that 
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Schematic diagram showing the factors that control pineal 
hormone secretion (7) and the delivery of pineal hormones to t arget 
organs. Noradrenaline is released from postganglionic sympathetic 
nerves (3A and 4A). The rate of release is suppressed by l ight (lA). 
Noradrenaline acts via ~-adrenoceptors in the pineal gland (4A and 4B). 
(Wurtman and Moskowitz, 1977). 
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melatonin has a direct action on the thyroid gland. The effect on 
TSH would be due to a decrease in plasma thyroid hormone owing to 
i~hibition of its synthesis or release in the thyroid. 
The pineal gland could thus influence the thyroid gland by: (1) a central 
action on neural centres controlling TSH or on the pituitary gland, or 
(2) by direct action on theo thyroid. 
1.4.4 The Pineal Gland 
Freire and Cardinali (1975) found that melatonin administe-ed subcutaneously 
to rats or exposing them to constant darkness f or 14 days induces changes 
in pineal ultrastructure characteristic of increased pineal activi ty. 
Ribosomes, procentrioles, microtubules, nucleoli and golgi apparatus 
are all increased in number . The activi ties of SNAT and HIOMT are 
also increased . Microtubule protein content increases by 85%. 
Pineal noradrenaline turnover is unaffected. The pineal gland is 
possibly a t a rget organ for exogenously administered melatonin . 
1. 5 DIVERSE EFFECTS OF MELATONIN 
Barchas et al . (1967) showed that melatonin administered to mice 
--
(25 mg/kg i.p.) increased the hexobarbitone (100 mg/kg i.p.) sleeping 
time by 50%. Marczynski et al. (1964) found that melatonin implanted 
into the hypothalamus of the cat induc,.d sleeping behaviour . A dose 
of 2,5 mg/kg i.v. also caused 4- day old chicks to assume the roosting 
position (Barchas et al., 1967) . This sleeping effect could be due 
to an increase in brain s erotonin concentration caused by melatonin 
admini stration . (Anton- Tay et al. , 1968 ). Melatonin has no detectable 
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effects on vertebrate blood pressure and does not alter the vasoactive 
effects of other substances such as noradrenaline and tyramine. Electro-
cardiograms are also unaltered . Kastin et a l. (1973) have found that 
melatonin injecti ons (200 ~g/180 g male rat) have no signifi cant effect on 
their locomotor activity . It is possible that the dose was too small. 
It has been show~ that uel atonin is capable of inhibiting rat liver 
N-acetyltransferase (Howd et al., 1976). This can be used as a basis 
for a melatonin assay where other methods are unsuitable. 
Anton-Tay et al. (1968), as a l ready mentioned (see page 5:)) found that 
i .p. administration of melatonin to rats increased brair. serotonin 
content by an unknown mechanism . They have however, shown that melatonin 
2 , 8 mg/kg i. p. does alter rat brain noradrerlaline concentrations. Fi ske 
and Huppert (1968) have found that subcutaneous injections of melatonin 
in young adult fema l e rats shif t or block the usual rhythm, depending on 
the time of day the melatonin was administered. 
Cotzias et al . (1971) have noted that an i.p. injection of melatonin 
(400 mg/kg) does not result in any significant altera tions in brain 
dopamine content. Howeve r , they were able to demons trate an increase 
in brain serotonin l~vels after melatonin administration . Piezzi and 
Wurtman (1970) found that da ily i.p. injections of melatonin (1 mg/kg) 
to male rats causes a 44% increase in the serotonin content of the pars 
intermedia of the pineal gland. Intra-arterial and intracisternal 
injections of melatonin cause an increase in rat brain dopamine and 
noradrenaline content (Wendel et al., 1974). One hour after an intra-
arterial injection of 250 fig/kg melatonin, the 6.o pamine content nearly 
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doubled and the noradrenaline content significantly incr"ased. An 
intracisternal injection had the same effect. Injection of 6- hydroxy-
melatonin, the main metabolite of melatonin , had no effect. 
Heldmaier and Hoffmann (1974) demonstrated that melatonin administer ed 
to hamsters increased browr. adipose tissue growth . This tissue is 
necessary for non-shivering heat production . Although they did not 
ascertain the mechanism by which this growth occurs , they concluded 
that it was unlikely to be due to ar- effect on the thyroi d gland , but 
rather a dirt'ct effect. Narang et a1. (1967) reported that me l atonin 
injections of 50 ~g depressed food intake in rats by about 10%. 
Melatonin also causes bronchcdilation in the dog (Rahamimoff et al. , 
1965) and inhibits the spontaneous contractions of isolated rat uterus 
(Hertz- Eschel and Rahamimoff , 1965). Melatonin apparently competitively 
i nhibits smooth muscle contraction induced by serotonin. 
1. 6 POSSIBLE ANTIGONADOTROPHIC SUBSTANCES 
1. 6 .1 Serotonin 
Some investigators have described ser otonin as a pineal anti gonadot rophic 
agent. It has been shown that serotonin implants into the brain depress 
pituitary level s of bioassayable FSH, suggesting that serotonin may play 
a role in the control of gonodotrophin production and release (Fraschini 
and Martini, 1970). 
1.6.2 N- Acetylserotonin 
Not much work has been done to determine the hormonal activity of this 
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indole compound and some reports about i t s activity seem contradictory. 
According to Porter et al. (1971-72), intraventricular admini strat ion 
--
of N-acetylserotonin 0= rats gives rise to elevated levels of LH in 
the plasma. Another publication from the same laboratory however, 
states that N- acetylserotonin inhibits LH release from the pituitary 
(Kamberi et a l., 1971). 
1. 6 . 3 5-Hydroxytr yptophol 
This substance does not seem to alter ovarian growth or inhibit t he 
oestrous cycle in the rat (McIsaac ~ al., 1964) but does inhibit 
compensatory ovarian hypertrophy in unilaterally ovariectomised mice 
(Vaughan et al ., 1972). It also reduces the percentage of immature 
rats which ovulate after subcutaneous administrat ion of pregnant mares 
serum (PMS) (Pomerantz and Reiter, 1974). It is possible that it acts 
by restricting the synthesis of LH by the anterior pituitary of the rat 
(Fraschini and Martini , 1970). 
1.6.4 Polypeptides: Arginine Vasotocin 
Arginine vasotocin (AVT), a biologically active octapeptide, was identified 
in pineal extracts by Mi lcu et al. in 1963. It was found to be a potent 
inhibitor of reproduction in immature rodents pretreated with gonado-
trophins, its effect on endocrine tissues being abovt a milli on times 
greater than that of melatonin. Pave l. and Petrescu (1966) found that 
AVT inhibited PMS-induced hypertrophy of ovaries in immature mice while 
Mo szkowska et al . (1968) and Vaughan et al. (1975) found that it inhibited 
the HCG-induced hypertrophy of ovaries and uterus in immature mice. 
These latter workers have also shown that daily injections of AVT prolonged 
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oestrous cycles and caused abortion in mice (Vaughan et al., 1976) . In 
addi tion, it is known to be capable of blocking COmp E-llsatory ovarian 
hypertrophy after unilateral ovariectomy and reducing the size of the 
reproductive organs when injected into young male a~d female mice. 
This retarding effect seems to be specific as no other orga~s were 
affected. 
Pavel (1973) showed that an injection of melatonin could induce AVT 
release from the pineal gland, the only known source of it in mammals. 
It has therefore been suggested that melatonin is possibly only an 
intermediate in neuroendocrine transduction i.e. a releasing factor 
for AVT , which is the final effector. This would then adequately 
account for the antigonadotrophic properties of both substances. 
However, it fails to account for t he action of melatonin on pinealectomised 
animals . 
Other structurally unidentified compounds of a peptidic nature have 
been isolated from mammalian pineal glands. 
gonadotrophic activity. 
1.6.5 GABA 
These also possess anti -
Mata et al. (1976) investigated the possible role of GABA in the pineal 
gland. . They were unable to establish its exact function , but concluded 
that GABA content is not inf luenced by l ight, is not affected. in any way 
by the a drenergic nervous system and it in turn has no modifying effect 
on the adrenergic nervous system. 
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1.7 ENDOCRINE EFFECTS ON THE PINEAL GLAND (REVERSE EFFECTS) 
1.7.1 Pineal Biochemistry (See also 1.8) 
Although much work has been done on the effects of the pineal on other 
organs, very little research ~as been done on the reciprocal effects of 
gonadal and other hornones on the pineal. The pineal has the capacity 
to respond to a variety of hormonal signals in the circulation. These 
include gonadal steroids (Cardinali et al., 1974a; Nagle et al. , 1975) 
and catecholamines (Lynch et al. , 1973a). 
Wurtman et al . ( 1965) report ed that pineal HIOMT activity in female 
rats is two-fol d higher during dioestrous than during oestrous. Although 
castration does not affect pineal activity , oestradiol benzoate ~~s been 
shown in inhibit pineal HIOHT activity (Wurtman et al. , 1965); 
Alexander et al., 1970). However, Houssay and Barcelo (1972) have 
reported that caily injections of 20 Mg of oestradiol benzoate into 
ovariectomised female rats has a stimulatory effect on pineal HIOMT 
activi t y and that progesterone decreases HIOMT activity. It appears 
that low doses of oestradiol bellzoate have a stimulatory effect on HIOMT 
and that higher doses are inhibitory. Oestrogens , apparently , have 
little effect on SNAT activity (Preslock, 1977). Weiss and Crayton 
(1970) have demonstrated that p:cogeste:"one is ineffective in reversing 
the noradrena l ine-induced increase in pineal adenyl cyclase activity , 
but Houssay and Barcelo (1972) showed that it can decrease HIOMT activity. 
Nagle et al. (1974) have shown that castration decreases HIOMT 
activity in pineals of male rats and that testosterone propionate 
injections restore the activity. Higher doses of this substance however , 
decrease pineal HIOMT activity. 
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It has also been shown that the low dose oestradiol- induced increase 
in pineal HIOMT activity can be antagonized by simultaneous 
administration of noradrenaline. Cardinal i et al. (1974a; 1974b) 
have shown that oestradiol or testosterone enhances melatonin synthesis 
and this suggests the possibility of a negative feedback system between 
the gonads and the pineal gland. Sympathetic il".nervation is esse>1tial 
for the steroid to exer t such an effect (Nagle et al., 1975) and the 
--
change in pineal synthetic activity seems to be brought about by an 
increased eflux of noradrenaline from pineal nerve terminals (cardinali 
et al., 197 Sa) • 
Although the effects of gonadal steroids on the pineal have received 
much atte:'ltion, not much information is available on the influence of 
gonadotrophins on this organ. Cardinali et al. (197Sa) have demonstrated 
that gonadotrophin (LH and FSH) and prolactin injectior,s could induce 
HIOMT acti vi ty • Pineal denervation prevents this effect which seems 
to be a direct one. Experiments indicate that the stimulatory effect 
of the pituitary on HI OMT may decrease with age of the animal (Alexander 
et al., 1970). It is possible that the effect of pituitary ho rmones 
on the pineal may be effected through secretions from specific target 
organs. For example , any suggestions of gonadotrophin effects on the 
pineal must take into accour.t the effects of secretion of gonadal steroids 
because gonadotrophins such as LH are known to influence the sec-etion of 
gonadal steroids both from the ovary and the testis. 
Gonadectomy causes an increase in gonadotrophin levels (Gay and Midgley , 
1964) . Smith et al. (197S) investigated this phenomenon in a histo-
chemical and biochemical study and concluded that there seems to be no 
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effect of increased gonadotrophin levels on the pineal serotonin 
level. 
1 . 7 . 2 Pregnancy 
Huang and Everitt (1965) investigated effects of pregnancy on the 
pineal gland. They found that pineal mass in pregnant rats decreases 
as the pregnancy progresses and that pineal mass is inversely 
proportional to the number of foetuses carried . Induction of pseudo-
pregnancy was found to result in a significant change in pineal HIOMT 
rhythm from that measured during the oestrous cycle (Yochim and Wal len, 
1974a). Yochim and Wallen therefore suggested that the pineal gland 
may have a dual role in reprod uction: (1) as a transd ucer of photo-
periodic information for seas ona l breeding activity and (2) as a 
regulator of gonadotrophin secretion during the reproductive cyc l e, 
both phenomena being demonstrab l e in the rat. 
1.8 DRUG EFFECTS ON THE PINEAL GLAND 
1.8.1 a-Receptors, cAMP and Adenyl Cycl ase Activity 
The catecholamine, I - noradrenaline has been shown by Weiss and Costa 
(1967) to activate adenyl cyclase in pineal homogenates. This led 
to further investigation of the possible effect of various 
catecholamines on adenyl cyclase and cyclic AMP (Weiss and Costa, 
196 8). l-Noradrenaline, l-adrenaline and l-isoprenaline all 
increase adenyl cyclase activity. Substances such as serotonin , 
histamine, i.-noradrenaline, d l-normetanephrine, tyramine, dopamine, 
dl-dihydroxymandelic acid, i.-amphetamine or l-phenylephrine have 
no effect on the enzyme activity in pineal homogenates. Guanethid ine, 
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desmethylimipramine and cocaine, all of which alter sympathetic 
nerve impulses into the pineal, also have no effect. ~ - Blockers 
have been shown to antagonize the noradrenaline-induced stimulation 
of adenyl cyclase activity, whereas the a-blockers phenoxybenzamine 
and phentolamine have negligible activity. These results suggest 
that pineal adenyl cyclase responds selectively to specific adrenergic 
and adrenolytic drugs in a manner similar to that of a post junctional 
~-r eceptor. 
Weiss and Costa (1968) studied the effects of gonadal hormones in 
regulating pineal adenyl cyclase activity. They found adenyl 
cyclase in female rats to be less responsive to the stimulatory 
effects of noradrenaline than that of male rats. Testosterone 
propionate failed to alter adenyl cyclase activity in either male 
or female rats . Noradrenaline was found to activate adenyl cyclase 
in female rats at oestrous, metoestrous or dioestrous. Adenyl 
cyclase of rats at prooestrous failed to respond. This find ing 
suggests that female sex hormones may inhibit the enzyme since 
oestrogen , progestin and gonadotrophin levels rise during prooestrous. 
Further investigation showed that progesterone alone has no significant 
effect on adenyl cyclase when administered to ovariectomised rats. 
Oestrad iol plus progestero,,"e co.npletely abolishes the noradrenaline 
stimUlatory effect on adenyl cyclase and markedly reduces the response 
of the enzyme to sod ium fluoride . Oestrogen alone also inhibits the 
noradrenaline-induced activity without affecting the basal level of 
adenyl cyclase. Ovarian hormones seem, therefore, to affect the 
pineal gland and this suggests the possibl ·e presence of a hormonal 
(as well as neuronal) control of pineal adenyl cyclase activity and 
cyclic AMP levels. This suppressant effect of oestrogens may be a 
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direct one on pinealocytes or an indirect one modulating neuronal 
input. Furthermore Cardinali ~ al. (1975a) showed that treatment 
of rats for 3 days with testosterone or oestradiol increases nor -
adrenaline turnover without affecting the overall transmitter levels 
in the gland. These steroidal effects seem to tie in with Weiss 
and Costa's observations on adenyl cyclase activity at prooestrous 
and suggest strongly the presence of a feedback mechanism regulating 
gonadal function by altering the rate of pineal antigonadotrophin 
synthesis and release. In theory, gonadal hormones could accelerate 
noradrenaline turnover by acting (a) at any point of the multisynaptic 
neural pathway between the retina and pineal gland, (b) at the level 
of pineal nerve endings, or (c) through a hypothetical feedback loop 
involving the pinealocytes, which are target cells for sex steroids. 
The sensitivity of these target cells to steroids may possibly 
fluctuate with changing noradrenaline levels. 
1.8.2 Aromatic L-Amino Acid Decarboxylase Activity 
Drugs interfering with peripheral sympathetic nerve impulses to the 
pineal gland, e.g. guanethidine and bretylium, were administered by 
Snyder et al. (1965a) to rats (20 mg/kg for both drugs) to determine 
their effect on the response of the enzyme to constant light. 
Bretylium blocks the rise of the enzyme level but guanethidine has 
no effect. Both drugs were found to block the constant light-
induced reduction in pineal mass. These effects are probably due 
to the neuronal blocking ability of the two drugs. Why guanethid ine 
has no effect on enzyme activity in this case is unclear. Trentini 
et al. (1973) showed also that bretylium and guanethid ine block the 
increase of pineal mass aSsoc iated with hyper gonad otrophinaemia, thus 
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suggesting that experimental hypergonadotrophinaemia affects the 
pineal by way of the sympathetic nervous system and not the blood -
stream. 
1. 8.3 Serotonin Production 
The monoamine oxidase inhibitor (MAOI) ~-phenylisopropylhydrazine was 
administered to rats to see if this could block the nocturnal drop in 
serotonin concentration in the pineal (Snyder and Axelrod, 1965) . It 
did so, suggesting that serotonin is released from a bound form at 
night, making it accessibl e to degradation by monoamine oxidase. The 
MAOI pargyline, however , has been shown to have no sign ificant effect 
on serotonin l eve ls after prior treatment with l - isoprenaline (Brown-
stein ~ al., 1973b). 
Se ro tonin rhythm, which appears to be controlled by s ympathetic nerves, 
is abolished by reserpine but guanethidine and bretylium have no effect. 
The latter two drugs thu s do not seem to a lter nervous impulses to the 
pineal gland in the same way as th!"y affect those of othl'r peripheral 
sympathetic nerves. 
Hyyppa ~ al. (1971) found that i n traperi toneal dosing of rats with 
~-dopa plus a peripheral decarboxylase inhibitor resulted in a drop 
in pineal serotonin content. This could be due to conversion of 
some of the ~-dopa in the eNS to noradrenaline, which, when acting 
on pineal ~-receptors, Causes an increase in SNAT activity and 
therefore a drop in pineal serotonin level. 
Isoprenaline was shO'.oIn in !2.~ to cause a fal l of seroto:Jin levels 
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during the day. Propranolol, a j3 -adrenergic blocker, reverses this 
fall. Phentol amine, an a-adrenergic blocker, is without effect. 
l-Propranolol,co~verBel~ causes a rapid increase in serotonin 
concentration a t night when its levels are normally low (Brownstein 
~ al., 1973b). 
1.8.4 Serotonin N- Acetyltransferase Activity 
Rat pineal SNAT activity is markedly and rapidly elevated ~ ~ 
after subcutaneous injection of drugs such as ~-dopa, n oradrenaline , 
adrenaline, isoprenaline, monoamine oxidase inhibitors or theophylline 
(a phosphodiesterase inhibitor)(Deguchi and Axelrod, 1972a). The 
effect of MAOI's is apparently not due to stimulation by serotonin, 
the oxidation of which is prevented by the inhibition of MAO, but 
rather due to inhibition of noradrenaline catabolism (by MAO), which 
leads to a greater stimulation of SNAT activity (Klein and Weller, 
1970b ). j3 - Blockers and protein synthesis inhibitors completely block 
the effect of these drugs, suggesting that their effects are mediated 
via the ~-adrenoceptor and require the synthesis of new enzyme 
molecules. It is assumed that ~-dopa acts by being converted to a 
catechol amine, possibly noradrenaline. Phenox ybenzamine, (an a-
adrenoceptor blocker), i s unable t o block the stimQlatory effects of 
these drugs on SNAT activity (Deguchi and Axelrod, 1972a). Mono-
amine oxidase inhibitors probably act by raising catecholamine 
concentrations. On the assumption that pargyline, an MAOI, Can 
increase noradrenaline concentrations in the brain by inhibiting 
the breakd 0I;n of th i s catecholamine , Illnerova (1974) administered 
the drug to rats to determin e its effect on pineal SNAT activity. 
When it was given during the day, a transient decrease, then an 
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increase in SNAT activity occurred. Pargyline however, did not 
block a iecrease in SNAT activity at night after exposure to light. 
It seems that noradrenaline levels decrease not because of an action 
by MAO but because of nervous reuptake and/or action of catechol-O-
methyl transferase (COMT). The stimulatory effect of theophylline 
suggests that the effect of the aforementioned drugs is mediated 
via cyclic AMP. 
The diurnal rhythm of SNAT, which increases in activity at night and 
drops off during the day, is abolished by reserpine (which depletes 
noradrenaline stores in nerve endings), further emphasizing that the 
activity of the enzyme is controlled by release of noradrenaline from 
nerve terminals (Deguchi ani Axelrod, 1972b ). 
Other factors such as stress induced by phys ical immobilization, or 
insulin-induced hypoglycaemia, have been shown by Lynch ~ al. (1973b) 
to cause an increase in pineal SNAT activity, which can be blocked 
by propranolol suggesting that these responses are also mediated by 
a catecholamine acting on the ~-receptor. This aga i n could either 
be due to noradrenaline being released from the nerve terminals or 
adrenal ine being released from the adrenal medulla. The latter 
mechanism is a strong possibility as sympathetic denervation of the 
pineal actually p otentiates the stress induced increase in SNAT 
activity. 
Ba ckstrom (1977) used an organ culture to investigate and categorize 
the ~-adrenergic receptor of the pineal gland. The non-selective 
~-receptor antagonist, ~-propranolol and the selective ~1-r eceptor 
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antagonist, practolol, both decrease the amount of[ 14C]_N_acetyl_ 
serotonin formed by the pineal when it is stimulated by the directly-
acting II-adrenergic agonist terbu tal i ne. To cause a 5 0% 
decrease in [14g -N-acetylserotonin, compared with that formed by 
terbutaline alone, a 1000-times greater concentration of practolol 
than propranolol is need ed. Two selective ~2-receptor antagonists, 
butoxami ne and H35/25 , have no effect or a minimal effect respectively 
on this system. These results indicate that pineal adrenoreceptors 
in an organ culture behave as ~1-receptors. 
Holz ~ al. (1974) also used an organ culture to investigate the 
stimulatory effects of certain drugs on SNAT iniuction in intact 
and denervated pineal glands. They found that cocaine, procaine, 
pheniprazine, veratridine and the absence of potassium stimulates 
SNAT in innervated but not in denervated pineals. The stimulatory 
effects increase enzyme activity 100 to 2000-fold and this can be 
blocked by propranolol. It was concluded that these drugs and 
lack of potassium act on nerve terminals to cause an accumulation 
of extra-neuronal noradrenaline, which stimulates, a ~-receptor to 
induce proiuction of SNAT. In the case of veratridine, it was 
suggested that it works not only by inhibiting noradrenaline uptake, 
but also by stimulating its release. 
Al tho"<>gh the oestrogen, oestrad iol has been shown by Weiss and Crayton 
(1970) to suppress adenyl cyclase-cyclic AMP function in vitro, 
Illnerova (1975) was unable to demonstrate any effect of oestradiol 
22! ~ on SNAT which is assumed to be controlled by the "second 
messenger" . This finding suggests that SNAT activity is not in 
fact un i er c ontr ol of t h e " second me ssen ger " or t h a t the 
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activation of adenyl cyclase by noradrenaline is not suppressed to 
the same extent in vivo as in vitro. 
1.8.5 HIOMT Activity, Melatonin Production and Pineal Protein 
Synthesis 
Using an organ culture system , Axelrod ~ al. (1969) showed that, 
besides noradrenaline, structurally related compounds such as 
adrenaline, tyramin e, tryptamine and octopamine also stimQlate the 
formation Of[14C1_melatonin . Serotonin, melatonin and 5 - hydroxy-
indole - 3-acetic acid have no effect. Thi s stimulation was assumed 
to be due partly to adrenergic stimulation and partly to monoamine 
oxidase inhibition. Klein and Rowe (1970) also investigated the 
effect of harmine, a MAOI, on the production of mela ton in in an 
or gan culture system. They found that pineal gla~ds treated with 
harmine produce up to 5 times as much melatonin as untreated glands 
and that N-acetylserotonin levels are increased as well. Serotonin 
breakdown products l ike 5 - hydroxyindole-3-acetic acid, caused by the 
action of monoamine oxidase, were found to be present at reduced 
l evels. They concluded that, by inhibiting seroto~in oxidation, 
an enhancement of N-acetylation results. This yie lds N- acetyl-
serotonin and, hence , more melatonin can be produced by simple 
mass action. Houssay ani Barcelo (1972) found that oestrogen 
administration to rats produces a significant decrease in pineal 
mass and a mark ed increase in HIOMT activity. Progesterone 
however, while not affecting pineal mass, significantly lowers 
HIOMT activity . Although they did not offer an explanation, it 
seems likely that these observatio~s indicate the presence of a 
steroidal feedback system controlling HIOMT activity. This 
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phenomenon may be part of the same system mentioned by Cardinali 
!ll d. (1975a). 
Hartley ~ al. (1972) reported that the neuroleptic drugs haloperidol 
and flupl-lenazine inhibit pineal HIOMT activity 2E: vitro. They also 
found that psychotomimetic drugs such as dimethyltryptamine stimulate 
HIOMT activity in vitro by almost 30% (Hartley and Smith, 1973a). 
Other substances such as methoxybufotenin, mescaline and lysergide 
tartrate cause abo~t a 10% increase in activity. Seeing that 
haloperidol and fluphenazine, which are used to treat schizophrenia, 
inhibit HIOMT activity and therefore melatonin production in vitro, 
and that psychotomimetic drugs produce psychoses similar to those 
observed in schizophrenia, they suggest that melatonin production 
may be implicated in schizophrenic states. Altschule (1957) , 
Eldred ~ al. (1')61) and BigelmoJ ( 1974) have fOU.lld that aqueous 
pineal extracts exert a beneficial effect in some schizophrenics. 
The mechanism by which this occurs is not known. 
Hartley and Smith (1973b), continuing in this field, found that HIOMT 
catalyses the formatiofl of N-acetyl-3,4-dimethoxyphenethylamine 
(NADMPEA) from N-acetyl-3-hydroxy-4-methoxyphenethylamine and 
N-acetyl-4-hyd roxy-3-methoxyphenethylamine in .vitro. This conversion 
was found also to be inhibited by haloperidol, which is concentrated 
in the pineal gland more than in any other part of the brain (Naylor 
and Olley, 1')69). It seems that in schizophrenia, HIOMT may act on 
abnormal substrates such as isomeric methyl esters of dopamine to 
produce the dimethylated metabolites which have been implicated in 
the disease. This blockade of the formation of a psychotogenic 
amine would then offer a plausible alternative mechanism of action 
of haloperid 01. 
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Nir ~ al. (1976) found that the vitamin pyridoxal-S'-phosphate 
inhibits HIOMT activity and thus reduces the conversion of 
N-acetylserotonin to melatonin. Noradrenaline blocks this 
effect by forming a complex with the vitamin. Pyrid oxal - S' -
phosphate may therefore playa role in regulation of the activity 
of HIOMT and perhaps of other methyltransferases in the brain. 
Besides demonstrating that the pineal gland is a target for 
ovarian steroids, Cardinali ~ al. (1974a) have also investigated 
the effects of physiological doses of oestrajiol on HIOMT activity 
(and therefore melatonin projuction) which was found to be enhanced 
by the steroids. Furthermore, they found that oestradiol benzoate 
significantly increases [3H]-leucine incorporation into pineal 
protein in ~. If the apparent increase in protein synthesis 
reflects an increased production of pineal antigonadal peptides 
as well, this, together with the increased HIOMT activity, would 
provide the basis for an ovarian-pineal negative feedback system. 
With so ~uch evidence suggesting the presence of such a system, 
it seems most likely that it does exist. 
Wurtman ~ al. (196 9) used an organ culture to show that ! - noTadrenaline 
can profoundly increase the incorporation of[14g_tryptoPhan into 
Dopamine and I-adrenaline have similar effects, but 
dopamine is more potent, anj l-adrenaline less potent than I-nor-
adrenaline. Indoles such as serotonin have no effect. The 
mechanism by which noradrenaline exerts this effect is probably 
by enhancing the rate at which the amino acij enters pineal 
parenchymal cells. It may also increase intracellular specific 
activity. The amount Of[14c]_tryptoPhan incorporated into the 
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indoleamine biosynthetic pathway is however at least 40 times that 
incorporated into protein. 
1.9 EFFECTS OF SURGERY ON PINEAL AND RELATED FUNCTIONS 
1.9.1 Denervation 
The sympathetic nervous system wh ich innervates the pineal gland 
in mammals has its origins in the superior cervical ganglia in the 
neck (Kappers, 1960). Bilateral ganglio~ectomy involves surgical 
removal of both ganglia; decentralisation entails removal of a 
sectio~ of the preganglio~ic fibres of the ganglia (Moore and 
Rapport, 1971). Although it is generally accepted that the pineal 
stalk is of little importance with respect to pineal innervation, 
it has been demonstrated that disruption of the pineal stalk leads 
to a reduction in pineal size (Quay, 1971). 
Weiss and Costa (196 7) investigated the possible effects of bilateral 
superior cervical ganglionectomy (S.C.G.) on adenyl cyclase activity 
in the pineal gland. They found that there was little or no effect, 
although this procedure does sensitize the adenyl cyclase system to 
stimulation by noradrenaline. Wurtman ~ al. (1964c) had already 
shown that bilateral S.C.G. abolishes HIOMT rhythm by removing 
photic control of t hi s enzyme . This applies a lso to pineal serotonin 
rhythm (Fiske, 1964) which fluctuates diurnally in relation to the 
photoperiod (Quay, 1%3). Chu ~ al. (1954) found that melatonin 
had an inhibitory effect on the oestro·.ls cycle whereas pinealectomy 
increases the incidence of oestro~s. However, Brown-Grant and 
Ostberg (1964) found that pineal denervation had no significantly 
different effect from sham-operated animals regarding effect on 
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the oestrous cycle and ovulation. 
Moore and Rapport (1971) further investigated the effects of S.C.G. 
and decentralisation on HIOMT activity. They confirm that HIOMT 
response to light is abolished after these surgical procedures. 
It was found also that HIOMT activity levels are significantly less 
after decentralisation than after ganglionectomy, and these are in 
turn significantly less than constant-light control levels. This 
confirms that intact sympathetic innervation is necessary not only 
to enable it to respond to light, but also for normal rhythmic 
enzyme activity. Furthermore they found that denervation has a 
negligible effect on the oestrous cycle in the female rat. These 
findings agree with those of Brown-Grant and Ostberg (1974). Snyder 
~ al. (1965b) suggest that, alth9ugh serotonin rhythm is abolished by 
S.C.G., the rhythm is essentially intrinsic to the pineal gland but 
requires intact sympathetic nerves for expression . They thought 
initially that some controlling mechanism for the rhythm could be 
present in the ganglia, but as severing the preganglionic nerves 
has the same effect on the serotonin rhythm, this is obviously not so. 
1.9.2 Bilateral Orbital Enucleation (Blinding) 
This procedure has no effect on pineal serotonin rhythm, a finding 
which further confirms the endogenous character of the rhythm 
(Snyd er ~ al., 1965b) . Removal of other end ocrine gland s such as 
adrenals, thyroid, ovaries and pituitary also has no effect on the 
serotonin rhythm. 
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1.9.3 Pinealectomy 
In 1956, Holmes reported that pinealectomy in the rat has no apparent 
anatomical effect on the pituitary gland as seen under the light 
microscope. (It also has no effect on the renin content of the 
kidneys which is increased by hypophysectomy (Bruinvels ~ al., 1964). 
These findings suggest that pinealectomy either is of minimal 
p~ysiological significance or that its potential effects are obscure 
or slow in appearing. Blake (1976), by pinealectomising or sham-
pinealectomising and, in addition, subjecting rats to ovariectomy, 
showed that the pineal gland apparently has no major effect on the 
timing or magnitude of LH, FSH and prolactin release at prooestrous. 
The length of the oestrous cycle is also anaffected. Other workers 
have also investi gated this field in an attempt to arrive at more 
definite conclusions about the effects of pinealectomy. Piacsek 
~ al. (1969) reported that pinealecto~y causes an increase in 
ovarian size in hypophysectomised rats with pituitary transplants. 
However, in this case, relatively low ovarian and uterine masses 
indicate that oestrogen and gonadotrophin levels are far below 
normal so that the entire hypothalamic-pituitary-go~adal feedback 
system is probably altered. As a result, very small changes i~ 
pineal secretion could be magnified by acting on a very steep 
portion of a hypothetical dose-response curve. Reiter (1973) 
showed that pinealectomy is ineffective in preventing persistent 
oestrous in female rats placed in conditions of constant light. 
However, pinealectomised rats tend to show fewer four-day oestrous 
cycles than intact rats. The pineal also seems to have an influence 
in controlling cycle length during shorter periods of light (Hoffmann 
and Cullin, 1975). 
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Moszkowska ~ al. (1971) have reported that pinealecto~y result s in 
lowered hypothalamic seroto~in levels. Ca~dinali (1975b) found that 
the hypothalamic synaptosomes of rats which had been pinealectomised 
or pinealectomised plus superior cervical ga~glionectomised show a 
reduced uptake of serotonin, whereas noradrenal ine, d opamin e a~d 
gl utamate uptake are unaffected. The findings suggest a c lose 
relationship between pineal gland and serotoninergic systems in 
the brain. 
It is possible that pinealectomy does not have gross after - effects 
because pineal substances such as melatonin are still present in 
the body. Ozaki and Lynch (1976) foun:!. that pinealect omised rats 
still exhibit melatonin in their plasma and urine , a lthou gh the 
l eve l is only about 20% of tha t normally present. It was assumed 
that this melatonin comes from undiscovered extrapineal sources. 
These sources could be the enterochromaffin cells of the harderian 
gland . 
1.9.4 Hypophysectomy and Gonadectomy 
Zweens ( 1963 ) noted that ovar iectomy in young rats caus es a sharp 
rise in pineal phospholipid content. He assumed that since the 
phospholipid content varies with the oestrous cycle, this is a 
gonadal effect which is reinforced by the effect of ovariectomy. 
This surgical procedure apparent ly alter s the accumulati on of 
phospholipids due either to deprivatio~ of ovarian ho~mones or 
overpro:i ucti on of gonad otrophins. 
Ito and Matsu shima ( 1968) foun:i that hypophysectomy caUses degenerative 
- 74 -
cellular atrophy and nuclear changes in the pineal gland. Lupulescu 
(1968), in addition, reported that the numbers of ribosomes are 
reduced, secretory gra~ules are depleted, the endoplasmic reticulum 
atrophies and the mitocho~dria are altered . Alexander ~ al. (1970 ) 
reported that hypophysectomy of 53- day old rats reduces pineal mass 
and HIOMT act i vity, whereas ovariectomy has no effect on pineal mass 
in 28-day 01:1 rats but HI01~T activity is increased. Urry ~ al. 
(1972) found that hypophysectomy of young, immature male rats causes 
a decrease in pineal mass and HIOMT activity. In mature rats, only 
pineal mass is decreased. This suggests that the pituitary may 
release a substance necessary for growth and development of the 
pineal and of HIOMT activity. 
In an attempt to define a more precise relationship between HIOMT 
activity and reproductive cyclicity, Wallen and Yochim (1974b) 
tested the pattern of HIOMT enzyme activity after ovariectomy and 
oestrogen replacement in the rat. After surgery, mean enzyme 
activity is significantly reduced, but rhythmicity is maintained. 
Oestrogen replacement restores the overall level of activity. It 
WaS conc l uded that the ovaries are not necessary for maintenance 
of pineal rhythmicity, but a feedback relationship obv iously exists 
between ovarian fu~ction and the mean level of pineal HIOMT activity. 
(See also 1 . 7) . 
1 .9.5 Combined Blinding and Anosmia 
If female rats are rendered blind an:1 anosmic, this significantly 
increases their locomotor activity (Sackman and Reiter, 1977). 
Their frequency of defaecation is also increased. By pinealectomising 
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these animals, or by giving them melatonin implants, this increased 
frequency of locomotor activity is completely reversed. However, 
the frequency of defaecation is only partly reversed. It has so 
far not been possible to define the exact role of the pineal in these 
phenomena. Blinding als o abolishes HIOMT rhythm, which is dependent 
on light for its diurnal fluctuation. 
1.9.6 Lateral Hypothalamic Lesioning 
Heller and Moore (1965) found that lateral hypothalamic les i ons which 
section the medial forebrain bundle can produce decreased noradrenaline 
and serotonin levels in the brain and also abolish their rhythms in the 
pineal gland. These levels depend on the integrity of central fibre 
systems relevant to each particular amine. Axelrod and Snyder (1966) 
placed bilateral lesions stereotaxically which transected the medial 
forebrain bundle in the lateral hypothalamus of young male rats. 
This procedure Was shown to abolish the light-induced rhythm in HIOMT 
activity. It seems that this part of the brain is involved in 
transmission of impulses from the retina to the pineal gland. 
From this review, it can be seen that the pineal has become a f ocus 
of much attention. Although much work has been done, there is plenty 
of scope for further research. It was dec-ided ., tl:lerefore, to conduct 
an investigation into the effects of ~-adrello,-active sUbstances on 
pineal metabolism and see if they caused any secondary gonadal changes. 
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CHAPTER 2 
2.1 MATERIALS AND METH aD S 
2. 1.1 Animals 
Albino female rats of the Wistar strain were used. Animals were 
not more than 6 months old and the mass of each rat was approximately 
180- 200 g. Each rat, individually housed in a plastic cage, had 
free access to food and water. The animal room was lit by white 
2 fluorescent tubes to give a light intensity of 300 ~W/cm • Use of 
a timer enabled the amount of light and dark to be varied according 
t o requirements . The rats were maintained under a 12h/12h light/ 
dark regimen . The room was well ventilated and the temper ature 
c on trolled at 20 °C. 
2.1.2 Administration of Drugs 
Drugs were administered orally or intraperitoneally to rats on a 
mg/kg or mmol/kg basis. All drugs were dissolved in normal saline 
prior to administration. Pindolol and hexoprenaline sulphate were 
dissolved in very dilute acetic acid. A hypodermic needle of which 
the point had been rounded with epoxy resin, was used to dose the 
rats orally. 
2.1.3 Surgery 
Initial surgical work entailed dissection of the brain and local-
ization of the pineal gland . One atlas (The Stoelting Co.) was 
founi to be inaccurate in its indication of the pineal location. 
By trial and error the gland was eventuall y located ani mapped. 
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This location agrees with . that given in another atlas (Skinner, 19'71). 
For the purpose of hardening the brain for dissection, freezing with 
liquid air proved to be impractical and therefore brains were removed 
from the skull and fixed in 10-20% formalin solution prior to 
dissection. 
Surgery was undertaken to establish the precise location of the 
pineal gland and to become familiar with the technique of pinealectomy. 
Several d ifferen t method s were tried. The rat was anaesthetized 
with pentobarbitone (40-60 mg/kg i.p.) and placed in a stereotaxic 
apparatus. The scalp of the rat was then incised and the skull 
scraped clear of tissue between the bregma and the lambda to a width 
of 3 mm on either side. With the aid of a dental drill, a plate of 
bone approximately 4 mm x 7 mm was remo'led directly over the pineal 
gland where the lambda and sagittal sutures interse c t. Alternatively, 
bone just anterior to the lambda suture and lateral to the sagittal 
suture was removed, leaving the intact dura mater exposed (fig. 16). 
Because of the presence of large venous sin-~ses above the pineal, it 
was found to be extremely difficult to pinealectomise the animal 
without causing severe bleeding. A pair of fine iridectomy forceps 
was inserted through an incision in the dura mater and the pineal 
gland grasped and removed as rapidly as possible. A dissecting 
microscope was used to facilitate this procedure. The bone chip 
was replaced and the skin sutured back into place. The rat was 
allowed to recover in a warm place. 
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Female rats were founi to be far more difficult to pinealectomise 
than male rats. They tended to bleed more and were also more 
vulnerable to the effect of the anaesthetic. This resulted in 
high mortality. 
Other anaesthetics were tried in an attempt to overcome this problem. 
Alfathesin(R) has virtually no anaesthetic effect at all, even in 
large doses. Combination anaesthesia using ether or halothane plus 
pentobarbitone Was found to be unpredictable in effect and unreliable. 
2.1.4 Electrocardiogram 
As it was envisaged that rats would in due course be dosed with 
~ -adrenergic sympatho:nimetics and sympatholytics, it was decided to 
monitor the heartbeat of the rat as an approximate parameter for 
determining the amount of drug to be administered. An ECG machine 
was linked up to a rat under anaesthesia. Hypodermic needles 
soldered to leads were embedded under the skin of the rat. The 
standard 3-lead system (lead III) was used. The chart speed was 
25 mm/s. A very clear ECG was obtained in this way and it was 
possible to get a reasonable assessment of the effect of the drug 
on chronotropic activity. However, the anaesthetics used, viz. 
pentobarbitone (~ 40 mg/kg), ether and halothane, also had an effect 
on the heart rate. Moreover, it was found that many of the 
~ -adrenergic blocking drugs had some intrinsic stimulatory activity, 
thus making it difficult to adjust dose levels on the basis of heart-
beat alone. The system was therefore used to give an approximate 
indication of ~-receptor blockade. (Fig. 17). 
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o 
Fig. 16. Dorsal view of rat skull showing where bone was removed 
for pinealectomy. 
b, bregma suture; 1, lambda suture. 
Fig. 17. Example of a rat ECG (lead III). 
a. normal ECG; b. after administration of propranolol 20 mg/kg. 
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2.1.5 Vaginal Smears 
A cotton bud, dampened with a small amount of water, was inserted 
into the vagina to ootain vaginal material for the assessment of 
the stage of oestrous of the rat. The smear was placed on a glass 
slide with a drop of water and examined under a magnification of 100 . 
Cell cornification indicates the state of oestrous. 
Vaginal smears were taken between 09hOO and 10hOO every day. Only 
rats which exhibited regular cycles were used for experimental work. 
2.1.6 Thin-Layer Chromatography (TLC) 
TLC was undertaken to develop solvent systems for the separation or 
identification of pineal indole compounds. Several systems were 
tried (tables 1; 2). 
results. 
Solvent system 4 was found to give the best 
2.1.7 Assay of Pineal Enzymes by Liquid Scintillation Counting 
The pineal gland is heavily innervated by the sympathetic nervous 
system (Kappers, 1960), and it is apparently not protected by the 
blooi -brain barrier. Only ,,-receptors have been found in the pineal 
and therefore it seemed likely that drugs acting on the ,,-adreno-
ceptor would affect pineal metabolic function. In fact, the effect 
of ,,-active drugs on pineal gland enzymes, especially on SNAT, which 
is under control of adenyl cyclase-cyclic AMP second messenger system 
(Klein ~ .al ., 1970b), has been demonstrated by several researchers 
(Weiss and Costa, 1968; Deguchi and Axelrod, 1972a; 1972b; Romero 
ani Axelroi , 1975). It was decided, therefore , to investigate 
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TABLE 1 
SOLVENT SYSTEMS TRIED FOR INDOLE COMPOUNDS 
NO. SYSTEM REMARKS 
1 methyl acetate:isopropanol:ammonium hydroxide (45:35:20) satisfactory 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
methyl acetate:isopropanol:ammonium hydroxide (50:30:20) 
ethyl acetate : glac i al acetic acid:water (30:30:20) 
ethyl acetate:isopropanol:ammonium hydroxide (45:30:10) 
methyl acetate:isopropanol:ammonium hydr oxide (45:30:10) 
n-butanol:pyridine:glacial acetic acid:water (30:4:10) 
ethanol:ethyl acetate:ammonium hydroxide : water 
(10:10:1:4) 
chloroform:glacial acetic acid (95 : 5) 
n-butanol:glacial acetic acid:water (15:3 : 5) 
ethyl acetate:glacial acetic acid:water (15 :1 5:10) 
sodium chloride 8% in water 
n - butanol:ethyl acetate : pyridine :glacial acetic acid: 
water (20:10:7:7:5) 
good 
poor 
excellent 
g ood 
moderate, 
s low 
discrete 
spots; too 
closely spacec 
virtually 
ineffective 
poor 
good, but 
causes tailin , 
very slowj 
high Rf value 
wi th poor 
separation 
very good; 
comparable 
with 4 and 5 
- 84 -
TABLE 2 
EXAMPLE OF Rf VALUES OBTAINED USING SILICA GEL G 
-
SUBSTANCE SYSTEM 1 2 If 9 10 
trypt ophan Rf 4,9 5 1,5 8,5 4,5 
tryptamine 7,7 8,1 8,5 8 ,3 6,5 
5-hydroxytryptam ine 5,9 7 6,5 8,2 5,8 
5-hydroxyindole-3-acetic acid 5,6 5,8 4,2 8 ,4 8,0 
indole 5,6 6 3,3 - -
TABLE 3 
VISUALIZERS USED FOR TLC 
NO. VISUALIZER REMARKS 
1 Iod ine Vapour good , general purpose 
v isual izer 
2 Ehrlichs Reagent good 
3 Ninhydrin/ethanol/glacial acetic acid pale spots, not very 
sensitive 
4 Ferric chloride/potassium ferricyanide good 
5 Phosphomolybd ic acid/ ethanol/hyd ro-
chlor ic acid good 
6 Ultraviolet light short and long wave 
not active 
--
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further the possible effects of ~-active substances on pineal gland 
SNAT and HIOMT activities, especially the latter as, although its 
activity was known to be modified by light (Wurtman ~ al., 196 3b; 
Axelrod ~ ~., 1965), very little was known about the possible 
direct sympathetic influence on this enzyme. It had also not been 
conclusively established whether adenyl cyclase was responsible for 
controlling the activity of HIOMT. An attempt was made to correlate 
the effects of these drugs on pineal enzymes with the effects observed 
on the oestrous cycle of the rat. 
The assay of HIOMT used is a modification of that developed by Axelrod 
and Weissbach (1961). The assay is based on the transfer of a 
radioactive [ 14CJ-methYl group from the methyl donor, S-adenosyl- k-
[methyl_14c]methionine to the substrate N-acetylserotonin to form radio-
active melatonin (N-acetyl-S-{ met hoxy- 14C ):ryptamine). HI OMT is 
responsible for the formation of melatonin from N- acetylsero tonin . The 
amount of radioactive melatonin formed can be detected by liquid scintillo-
metry and this can be used as a par ameter for enzyme activity. 
Rats were killed by a blow on the neck followed by decapitation. The 
pineal gland was rapidly removed by cutting off the top of the skull 
with a large pair of scissors. Groups of 3 pineal gland s were pooled 
and after all extraneous tissue had been removed, their mass was 
determined on a Sartorius analytical balance accurate to 0,1 mg. 
All three glands were then homogenized in 1,5 ml ice-cold 0,05 M 
phosphate buffer , pH 7,9, in a 1 ml glass homogenizer with a teflon 
pestle. As the quantity of tissue is very small, it was found that 
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homogenization by hand was quite adequate. The pestle was taken 
through 8 excursions of the homogenizer tube. This provided 
adequate mixing and homogenization. 
S-Adenosyl-lo-[ methyl- 14C] methionine was supplied by The Radiochemical 
Centre, Amersham in glass bottles of 5 ~i each. The rad ioactive 
material Was diluted to a volume containing 1 nCi/~l and quantities 
of 500 nCi were stored in glass vials at -20 °C. 
Glass scintillation vials (Beckman "Extra" vials) were used for 
incubation purposes. Six vials were used for each group of 3 
pineals. Prior to incubation, 200 ~l aliquots of the pineal 
homogenate were placed in each vial containing 50 ~ g N-acetylserotonin 
in 50 ~l phosphate buffer and 20 nCi S-adenosyl-~-[ methyl- 14CJ-
methionine (specific activity 0,4 - 0,5 mCi/mmo l l in 20 ~l H
2
S0
4
, 
pH 3. A tissue blank in which brain cortex was substituted f or 
pineal tissue and a reagent blank in which tissue was om itted were 
incubated along wi th every batch of v i als. The average calculated 
disintegrations per minute (d.p.m . ) for these two vials was sub -
tracted from the d.p .m. obtained with the other vials before 
conversion to picomoles of melatonin formed/90 min/mg pineal 
tissue. A BASIC computer programme was used for this calculation. 
The total incubation volume in each vial was 270 ~l. Init ially, 
50 nCi S-adenOSY1-~-[methYl-14cJmethionine was used , but the 
quantity was reduced as it is far in excess of that needed for 
transmethylation purposes and because there is a chance that 
S-ad enos ylhomocyste ine, the 
14 
of the [ CJ -me thyl group, 
resultant product after the removal 
may be present. S-Adenosylhomocysteine 
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has been shown by Deguchi and Barchas (1971) to be a potent inhibitor 
of HIOMT activity. The vials were incubated at 37 °c for 90 minutes 
in a shaking reaction incubator, the vials being agi tated very gently 
at 80 cycles per minute. The reaction was stopped by the addition 
of 1 ml 0,2 M borate buffer, pH 10, to each vial. This was followed 
by the addition of 8 ml chloroform to each vial by means of pipette 
with a pipette-sucker. Thereafter the vials were shaken for 10 
minutes on a mechanical shaker to transfer the radioactive melatonin 
formed to the organic phase. The aqueous phase Was removed by 
aspiration with a pasteur pipette attached to a suction venturi on 
a water tap, another 1 ml borate buffer was added and the organic 
phase washed by Shaking for a further 5 minutes. After removal of 
the aqueous buffer phase, 4 ml aliquots of the chloroform layer were 
pipetted into clean scintillation vials and evaporated to dryness in 
o 
a water bath at 75 C. (Chloroform is a powerful quench ing agent 
in liquid scintillation counting and therefore had to be removed.) 
(R) The residue was taken up in 1 ml ethanol, 10 ml Istagel (Packard 
Instrument Company) added to each vial which was then counted in a 
Beckman LS3150T liquid scintillation counter. A quench-correction 
curve was drawn up using a set of Beckman quenched standards. This 
curve, in conjunction with an external standard channels ratio (ESCR), 
obtained from the scintillation counter printout, was us ed to convert 
c .p.m. to d.p.m. Each sample was counted three times (20 minutes for 
each count) and the mean c.p.m. value calculated. To facilitate 
processing of results, a Wang mini-computer model 2200 was used. 
Programmes in BASIC were designed to calculate mean ESCR values and. 
convert c.p.m. to d.p.m. The d.p.m. values were then converted to 
picomoles of substance formed over a period of 90 minutes and expressed 
as picomoles/period of time/pineal gland or picomoles/perioi of time/ 
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mg pineal tissue. Statistical programmes were also used. The 
Students t-test was used to evaluate significance. 
As a precautionary measure, both S-adenOSyl-f-[methyl-14CJ methionine 
and N-acetylserotonin were checked chromatographically for impurities 
by spotting onto TLC plates (Gelman ITLC type SA). For the methyl 
donor, two solvent systems consisting of (a) n -butanol:glacial acetic 
acid:water (15:3:1) and (b) sodium chloride 8% in water were used. 
With the first system, one discrete spot (Rf ~ 0,2) was seen. The 
second solvent system gave a single spot with an Rf value of 0,68, 
showing the substance to be chromatographically pure. Two solvent 
systems consisting of (a) benzene:methanol : glacial acetic acid (94: 
5: 1) and (b) chloroform:methanol:glacial acetic acid (94:5:1), were 
used to check the purity of N- acetylserotonin. Both systems gave 
single spots, the Rf values being 0,18 and 0,32 respectively. 
The method of assay used is a m01ification of that developed by D eguchi 
and Axelro:i (1972c). The principle of the assay involves acetylation 
of tryptamine with [1_14C] acetyl -coenzyme A. SNAT is the enzyme 
responsible for the transfer of a radioactive acetyl group to 
tryptamine to form [14c1 -acetyltryptamine . This product can then 
be extracted into a non-polar solvent system i . e. toluene-isoamyl 
alcohol (97:3) and measured quantitatively by liquid scintillation 
counting . For each assay, four rats were used. The rats were 
killed by a blow on the neck and the pineal glands removed by cutt in g 
off the top of the skull, thus exposing the gland. After extrane ous 
tissue had been removed from each pineal, the mass of the glands was 
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determined as described previously and homogenized in ice-cold phosphate 
buffer (0,05 M), pH 6,5, containing tryptamine hydrochloride (3 x 10-3 M) 
14 
and [1- C]-acetyl-coenzyme A (15 nmol; specific activity 4,99 nCi/nmol, 
The Radi ochemical Centre, Amersham) with a 2 ml glass homogenizer and 
hand-held teflon pestle. The pestle Was taken through 8 excursions 
of the tube to ensure adequate homogenization of the tissue. 
The homogeni zer tubes were incubated at 37 °c for 15 minutes in a 
shaking reaction incubator. The tubes were agitated gently at 80 
cycles per minute. The reaction was stopped by the add i tion of 0 ,2 M 
borate buffer, pH 10. A total of 2 ml of the buffer was used in small 
quantities to rinse out each tube thoroughly. A pasteur pipette was 
used to transfer the contents of the tubes to a 6 ml glass -stoppered 
test-tube which contained 3 ml of toluene-isoamyl alcohol (97:3). 
After shaking on a vortex mixer for 30 seconds, the tube was 
centrifuged at 2000 r.p.m. for 5 minutes to separate organic and 
aqueous phases. A 2 ml aliquot 
into a scintillation vial, 10 ml 
of the organic layer was pipetted 
Instagel(R) scintillatio~ cocktail 
added a~d the radioactivity measured in a Beckman LS3150T liquid 
scintillation counter. Each vial was counted three times for a 
total of 60 minutes. The ESCR method of quench correction was 
used to convert c.p.m. to d.p.m. (see HIOMT assay) and the amount 
of [ 14C}acetYI tryptamine formed in 15 minutes calculated. Each 
assay was performed in duplicate and a blank incubation, in which 
brain tissue was sUbstituted for pineal tissue,was performed as wel l 
to determine background c .p. m. 
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CHAPTER 3. 
RESULTS AND DISCUSSION 
3.1 THE RAT OESTROUS CYCLE 
The pineal gland exerts an antigonadotrophic influence in rats 
(Wurtman et al., 1963a). Because the pineal is dependent on 
sympathetic nervous stimulation for indoleamine production (Axelrod 
~ al., 19(9), it was decided to investigate the possible effect of 
~-adrenoceptor blockade on the oestrous cycle of the rat. 
3. 1 . 1 Effect of Propranolol Hydrochloride 
A group of 20 individually- housed female rat~ each with a mass of 
180 g - 220 g,were selected for regularity of oestrous cycle. An 
attempt was made to block sympathetic activity during the 12-hour 
dark phase. Propranolol hydrochloride was chosen initially for its 
non-selective ~ -blo cking properties and also because of its lipo-
philici ty even thoagh it is thoaght that the pineal gland is not 
protected by the blood-brain barrier. 
A dosage of 20 mg/kg of the drug was administered orally twice daily, 
once 30 minutes before the onset of darkness and again 6 hours later. 
To ensure that the dose of propranolol was sufficient to suppress 
~-sympathetic activity over the whole 12- hour dark period, ECGs were 
taken while the rat was under light ether anaesthesia during the hour 
preceding the second dose and again during the hour preceding the 
light period. 
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Depression of chronotropic activity by 15% or more was taken as 
an indication of sustained ~-blockade. Doses of 10 mg/kg and 5 mg/ 
kg proved insufficient to prod uce ~-blockade of sufficient duration. 
The stage of the oestrous cycle was determined by taking vaginal 
smears and n ot ing the cell morphology and degree of cornification. 
The oestrous cycle of each rat was monitored daily at 09hOO and the 
number of positive oestrous smears taken over a 28-day period 
preceding drug dosage compared with the number of positive oestrous 
smears taken during 28 days of dosing. 
received normal saline . 
A control group of rats 
After 4 weeks , the data were anal ysed by using the Wilcoxon matched -
pairs signed-ranks test for significance. As no assumption had 
been made as to how the drug treatment would affect the oestrous 
cycles, two-tailed probabilities are quoted. 
From the data obtained it was found that the 10 rats dosed with 
propranolol gave a significantly greater number of positive oestrous 
smears, the oestrous cycle apparently being shortened (tabl e 4). 
This shortening may be explained on the basis of pineal ~-adrenoceptor 
b lockade. Blockade of these receptors before the onset of darkness 
should prevent th e surge in the activities of the pineal enzymes 
SNAT and HIOMT, result ing in reduced melatonin proiuction. Melatonin 
injections have been shown to reduce the incidence of oestrous (Chu 
~ al., 196 4) • Conversely, inhibition of proiuction of this anti -
gonadotrophic substance shouli increase the incidence of oestrous 
as was found to be the case in these experiments . 
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The above experiment was repeated under similar conditions but the 
propranolol was administered at 6-ho~r intervals during the light 
period • To determine the effect of different dose levels o~ 
propranolol on the oestrous cycle, 40 rats were used. They were 
divided into 4 groups of 10 rats each. The first 3 groLlps received 
propranolol hyd rochloride 20 mg/kg, 10 mg/kg, and 5 mg/kg respectively. 
The fourth group received normal saline. 
In this instance the oestrous cycle was lengthened. These results 
were again analysed for significance using the Wilcoxon matched-
pairs signed -ranks test (table 4). The first two groups , taken together 
showed a significant lengthening of the cycle (P < 0,050 two-tailed). The 
latter two group", taken together, showed no significant difference. 
Blockade of j3-adrenoceptors during the day, when sympathetic activity 
(and consequently pineal enzyme activity) is low, would not be expected 
to affect the oestrous cycle to any great extent. However, contrary 
to expectations, the results showed that the incidence of oestrous 
had been significantly diminished. The reason for this observation 
is not clear. It could however be due to an increase in super-
sensitivity of the j3-receptors which then respond to rising sympathetic 
activity during the dark phase by causing greater formation of melatonin. 
The an tigonad otrophic effect of melatonin woald then be responsible 
for prolonging the cycle. 
3.1.2 Effect of Acebutolol Hydrochloride, Metoprolol Tartrate 
and Oxprenolol Hydrochloride 
Five groups of 10 rats each were dosed orally during the day for 
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TABLE 4 
EFFECT OF B- ADENERGIC BLOCKERS ON RAT CORNIFIED 
OESTROUS SMEARS 
TOTAL TOTAL 
DURATION NO. OF NO. OF DOSE NO. TIME CORNI- CORNI-
DRUG USED mg/kg OF OF OF FlED FlED 
(oral) RATS DOSING DOSING/ SMEARS SMEARS DAYS BEFORE DURING 
DOSING DOSING 
1--
PROPRANOLOL 20 10 dark 28 65 79 
PROPRANOLOL 5 10 light 28 62 63 
PROPRANOLOL 10 10 light 28 65 55 
PROPRANOLOL 20 10 light 28 68 48 
ACEBUTOLOL 10 10 light 28 70 65 
ACEBUTOLOL 20 10 light 28 69 64 
METOPROLOL 10 10 light 28 70 63 
METOPROLOL 20 10 light 28 69 70 
OXPRENOLOL 10 10 light 28 65 67 
OXPRENOLOL 20 10 light 28 64 67 
NORMAL 
SALINE - 10 dark 28 68 70 
NORMAL 
SALINE - 10 light 28 70 67 
Each rat served as its own control. 
--
SIGNIFICANCE 
P <0,05 
N.S. 
P <0,05 
J P <0,05 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
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three weeks with acebutolol hydrochloride or metoprolol tartrate 
in the same manner as described in the previous experiment, in order 
to establish whether these specific ~1-adrenoceptor antagonists would 
be able to exert any effect on the oestrous cycle. The cycles of 
the rats were monitored for 28 days prior to dosing, two of the 
groups then received acebutolol hydrochloride or metoprolo l tartrate 
in a dose of 10 mg/kg. Two of th~ remaining groups received the 
same drugs orally, in a dose of 20 mg/kg, and a control group 
received normal saline. Rats were placed under light ether or 
halothane anaesthesia and electrocardiographs were taken t o give 
an indication of d osage levels to be used . However, interfering 
factors such as the effect of the anaesthetic and possible intrinsic 
sympathomimetic activity of the drugs precluded the use of the ECG 
for accurate or effective dose determination. 
The data were again analysed for significance using the Wilcoxon 
matched -pairs signed-ranks test. No significant alteration in the 
oestrous cycle was observed. The experiment was repeated with 
oxprenolol hydrochloride in a dose of 10 or 20 mg/kg. Again there 
was no significant effect on the oestrous cycle . (Taqle 4). 
The reason for this apparent inconsistency in the effect of 
propranolol on the oestrous cycle when compared with the other 
three ~-blockers used is not known. It is possible that the greater 
lipophilicity , greater binding constant or l ack of ~ or f2 - adreno-
ceptor selectivity of propranolol enables it to interact wi th 
~-adrenoceptors in the pineal gland or other parts of the brain 
such as the pituitary gland and thereby influences the oestrous 
cyc l e by altering gonadotrophin secretion. Too little acebutolol, 
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metoprolol ani oxprenolol may reach the brain to elicit any effect. 
Because of the inconsistency of these results and the fact that the 
experimental procedure is extremely time-consuming, it was decided 
to carry out more specific and selective experiments on the effec ts 
of the various ~-blockers directly on the pineal enzymes. 
3.2 HIOMT ACT IVITY 
In preliminary studies, counts proved to be low owin g to the very 
10" specific activity of the rad ioactive methyl donor (0,5 mCi/mmol) 
and the presence of very small amounts of the enzyme being assayed . 
In an attempt to improve the sensitivity of the assay and increase 
the number of counts, the duration of incubation was varied (fig. 18). 
The quantity of [14C] _me l atonin formed increased for a period up to 
approximately 100 minutes before levelling off. This reduction in 
the rate of [1 4c] _melatoni n produc tion could be due to the formation 
of S-adenosylhomocysteine which exerts an inhibit ory effect on HIOMT 
activity. The quantities of N-acetylserotonin and S-adenosyl-f-
[methyl 14C] methionine used were also varied, but this modification 
had little effect as the compounds were still both present in 
concentrations far in excess of that capable of being u tilized by 
the enzyme • Although equimolar quanti ties of N-acetylseroto!lin 
a!ld S-adenosyl-1-[methyl 14C]methion ine react to form an equimolar 
amount of [ 14C] _mela tonin , the quantity of radioactive methyl donor 
used Was reduced t o approximately half of that of N-acetylserotonin 
as no reduction in efficacy of the assay was noted and it also 
constituted a considerable saving on an expensive radiochemical. 
SDD 
14 ~u 
pmol [ CJ -
MELATONIN 
Fi~. 18. 
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• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
TIME;MIN 
HIOMT Activity (pmol [14C] _melatonin formed) Y.§.. time. 
There is a linear increase with time which falls off after 100 
minutes. 
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3.2.1 Effect of B-Adrenoceptor Blocking Agents 
An attempt was made to block the nocturnal rise in HIOMT activity 
by d osing female rats with propranolol 4 x 10- 2 mmol/kg 30 minutes 
before the onset of darkness. Control animals were dosed with 
normal saline. The rats were housed under a light/dark schedule 
of 12h/12h with the lights on from 22hOO to 10hOO. Three rats in 
metoestrous were used in both the test groClp and the control group. 
HIOMT activity fluctuates during the oestrous cycle and is at its 
highest at metoestro-clS (Yochim and Wallen, 1974a). The rats were 
killed in the dark five hours after being dosed, the pineals from 
each group pooled, and their combined mass and mean mass determined 
prior to being assayed for HIOMT activity. 
No significant difference Was noticed in HIOMT level s be twe en the 
t wo groups when the data were analysed by the Students t-test. 
Propranolol failed to block the nocturnal surge in HIOMT activity. 
This finding (a) may be due to an insufficient quantity of propranolol 
reaching the pineal gland to exert a measurable blocking effect 0r 
(b) it may be an indication that HIOMT activity is not under 
sympathetic ~-adrenergic control. 
Experiments with acebutolol hydrochloride and metoprolol tartrate 
confirmed the lack of activity of ~-blockers on HIOMT activity 
(fig. 19; table 5). 
3.2.2 Effect of [3--Adrenoceptor Stimulating Agents 
None of the ~-sympathomimetics, whether non-selective, selective or 
indirect-acting, seem to exert any appreciable effect on HIOMT 
Fig. 19. 
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pmol [14C] - MELATONIN/90 MIN/mg 
PINEAL TISSUE · 
Effect of ~-ad renoceptor blocking agents (4x10-2 mmol/kg) 
HIOMT activity (see table 5). 
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TABLE 5 
EFFECT OF 8-ADRENERGIC BLOCKING AGENTS ON HIOMT 
ACTIVITY 
HIOMT ACTFITY 
DOSE ROUTE ( pmol [1 C l- HIOMT DRUG OF MELATONIN/90 ACTIVITY (mmol/kg) DOSING MIN/mg PINEAL % 
+ TISSUE - S, E, M, 
ACEBUTOLOL 4x1 0- 2 277 + 8 96 p.o. -
4x10- 2 + METOPROLOL p.o. 295 - 6 103 
4x10-2 + PROPRANOLOL p.o. 273 - 8 95 
NORMAL SALINE 287 + 100 p.o. - 5 
SIGNIFICANCE 
not 
s ign i fican t 
not 
sign ifican t 
not 
signi fican t 
-
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activity (fig. 20; table 6). Had HIOMT activity been under 
adenyl cyclase - cyclic AMP co~trol,an effect should have been 
observed. It is possible that the availability of N-acetylserotonin 
or other factors may be of much greater importance than sympathetic 
stimul ation. Oral absorption of the drug was probably adequate so 
dosage by the intraperitoneal route was no more effective in 
influencing HIOMT activity. 
HIOMT activity has a relatively small amplitude of diurnal fluctuation 
(fig. 11a), thus alterations of levels are difficult to detect at the 
best of times. Any stimulatory or inhibitory effect on HIOMT activity 
by ~-active substances, unless ~ -sympathomimetics or the sympathetic 
nervous system was strongly impl icated in the co~trol of HIOMT activity, 
would thus be of a very low order, and could possibly go unnoticed. 
The only significant alteration in HIOMT activity noted was exerted 
by ephedrine hydrochloride which caused an apparent inhibition of 
enzymic activity (fig. 20). This could have been due to effects 
on higher centres in the brain as ephedrine has the ability t o cross 
the blood-brain barrier. Amphetamine however did not cause a similar 
decrease in activity thus mitigating against this explanation. 
3.3 SNAT ACTIVITY 
Vario~s ~-active substances were administered intraperitoneally to 
female rats in an attempt to alter SNAT activity. It hac;l been 
shown that ~-adrenoceptor agonists such as isoprenaline could markedly 
increase SNAT activity. ~-Adrenergic blocking agents such as 
propranolol had the opposite effect . This work was undertaken in 
, . 
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pmol [ 14C] - MELATONIN/90 MIN / 
mg PINEAL TISSUE 
II II 
tJ 
~ 
r_---+----4-----I------~--·----r_----~----~ 
Fig . 20 . Effe ct of ~-airenoceptor stimulating agents (mmol/kg) 
on HIOMT activity (see t able 6). 
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TABLE 6 
EFFECT OF S-ADRENERGIC SYMPATHOMIMETICS ON HIOMT 
DRUG 
ISOPRENALINE 
ISOPRENALINE 
ISOPRENALINE 
ETHYLN ORPHENYL-
EPHRINE 
ETHYLNORPHENYL-
EPHRINE 
FENOTEROL 
HEXOPRENALINE 
ORCIPRENALINE 
SALBUTAMOL 
AMPHETAMINE 
EPHEDRINE 
NORMAL SALINE 
-
ACTIVITY 
ROUTE DOSE OF (mmol/kg) DOSING 
1x10-2 p.o. 
2x10- 2 p.o. 
4x10-2 p.o. 
4x10-2 p.o. 
8x10-2 p.o. 
4x10- 2 p.o. 
4x10-2 p.o. 
4x10- 2 p.o. 
4x10- 2 p.o. 
4 -2 1, x10 p.o. 
4x1 0- 2 p.o. 
p.o. 
-- .... 
HIOMT ACTIVITY 
1 [ 14Cl -
TONIN/90 
mg PINEAL 
ISSUE ) 
E.M. 
(pmo 
MELA 
MIN/ 
T 
+ 
'" S. 
28 
26 
29 
29 
29 
31 
31 
27 
32 
27 
10 
2, 
-
7 :!: 16 
8 :!: 6 
1 :!: 10 
4 + 9 
9 :!: 6 
2 + 9 
9 + 7 
9 :!: 12 
+ 2 - 4 
+ 7 - 8 
8 + 7 
+ 5 - 0,5 
HIOMT 
ACTIVITY 
% 
97 
93 
101 
102 
104 
109 
111 
97 
112 
96 
73 
100 
SIGNIFICANCE 
not 
significan t 
not 
significan t 
not 
significant 
not 
significan t 
not 
sj gnif:i cant 
P< 0,01 
P< 0,02 
not 
significant 
P< 0,02 
not 
significan t 
P< 0,001 
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order to investigate further the effects of ~-sympathomimetic drugs 
and also, if possible, to determine the type of the ~-receptor 
involved in the stimulation of SNAT activity. The rats were again 
housed under conditions of 12 hours light and 12 hours dark wi t h 
light on at 06hOO and off at 18hOO. ~-Sympathomimetic drugs,when 
injected soon after the onset of the light phase, elicit a rapid 
rise in SNAT activity which soon declines to base levels again; the 
activity is not greatly increased . If the drug is administered later 
on in the day , induction of enzyme activity is slower but the activity 
also declines more slowly. The increase in activity h ow ever is much 
greater (Romero and Axelrod, 1975). Dosing rat s at midday and killing 
them 3 hours later gave optimal results. The time of dosing, and the 
period between dosing and killing enabled any alteration in enzyme 
activity to be easily detected. 
In cell cultures the p ineal cells maintain the ability to produce 
enzymes which respond to sympathomimetics. Thus pre - incubation of 
the pineal homogenate containing the en z yme for two h ours ,;ith the 
drug being tested was also tried to see if any activation of the 
enzyme ~ ~9. wO\lld result . 
noted. 
No effect on enzyme activity was 
3.3.1 Effect of a- Adrenoceptor Blocking Agents 
Female rats of mass 150 - 180 g were used . Under a lighting 
schedule of light fr om 06hOO to 18hOO and dark from 18hOO to 06hOO, 
groups of 4 rats were dosed i.p. at 11h30 with the blocking agent 
(4 x 10-2 mmol/kg). A control group of 4 rats was d osed i.p. with 
normal saline. At 12hOO, both gr o~ps of rats were dosed i.p. with 
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isoprenaline sulphate 2 x 10-2 mmol/ kg. At 15hOO, the rats were 
killed and their pineal glands assayed for SNAT activity . 
3.3 . 2 Effect of §- Adrenoceptor Stimulating Agents 
The assay of SNAT was performed under exactly the same conditions as 
with the blocking agents . The rats were dosed at 12hOO with equi-
molar quantities of different §- sympathomimetics, killed at 15hOO 
and the pineals assayed for SNAT activity. 
Irrespective of their selectivity, all the ~-adrenoceptor blocking 
agents used we r e active in significantly reducing the amount of 
[14C]-acetYltryptamine formed by SNAT (fig. 21; tab l e 7). The 
ability of isoprenaline t o stimulate SNAT activit y is ascribed to 
its activati on of adenyl cyc lase which converts adenosine triphosphate 
(ATP) to cyclic AMP which in turn controls the synthesis of SNAT 
enzyme protein (Klein ~ a l., 1970b). ~ -Blockers prevent the 
formation of cAMP by blocking the receptor which activates the 
adenyl cyclase. After induction with isoprenaline on an equimolar 
basis , pindolol showed the greatest blocking activity while acebutolol 
showed the least . Of the sympathomimetics used , isoprenaline exerted 
the greatest stimulatory effect on SNAT and amphetamine elicited the 
l east stimulatory activity (f i g. 22; table 8). 
From the result& no absolute conclusion can be drawn about the natur e 
of the ~-adrenoceptor of the pineal gland . The ~2 -selective stimulan ts 
i.e. fenoterol, orciprenaline, hexoprenaline and salbutamol exert much 
less s timulatory activity on SNAT than isoprenaline, suggesting that 
the receptors involved a r e probably of a ~1 nature. However, 
Fig. 21. 
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pmol[ 14C]-ACETYLTRYPTAMINE/15 MIN/mg 
PINEAL TISSUE 
,.. 
II 
PROPRANOLOL 
OXPRENOLOL 
PINDOLOL 
ACEBUTOLOL 
METOPROLOL 
BUTOXAMINE 
Effect of ~-adrenoceptor blocking agents (4 x 10-2 mmol/kg) 
on isoprenaline-induced (2 x 10-2 mmol/kg) SNAT activity (see table 7), 
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TABLE 7 
EFFECT OF B-ADRENERGIC BLOCKING AG~NTS ON 
ISOPRENALINE- INDUCED SNAT ACTIVITY 
SNAT ACTFITY 
DOSE ROUTE (pmol [1 CJ -SUBSTANCE (mmol/kg) OF ACETYLTRYPTAMINE DOSI NG FORMED/15 MIN/mg 
PINEAL TISSUE) 
:!:S.E.M. 
PROPRANOLOL 4 x10-2 i.p. 103,7 + 7 -
OXPRENOLOL 
" 
i.p. 54,3 + - 3 
PINDOLOL " i.p . 47,6 + - 5 
ACEBUTOLOL " i.p. 121,2 + 10 -
METOPROLOL " i . p . 99 ,4 + 19 -
BUTOXAMINE " i.p. 69,8 + - 2 
NORMAL SALINE i.p. 269 ,5 + 26 -
PERCENT-
AGE RE-
DUCTION 
BELOW 
NORMAL SIGNIFICANCE 
SALINE 
(RE-
LATIVE 
POTENCY) 
38,5 P< 0,0005 
20 P< 0 , 0005 
17,8 P< 0 , 0005 
44,8 P< 0,0005 
36 ,7 P< 0 , 0005 
25, 9 P < 0 , 0005 
100 p< 0 ,0005 
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14 pmal [ C] - ACETYLTRYPTAMINE/15 MIN/mg 
PINEAL TISSUE 
II 
ETHYLNORPHENYLEPHRINE 
FENOTEROL 
HEXOPRENALINE 
ORCIPRENALINE 
SALBUTAMOL 
AMPHETAMINE (1,4 mmal/kg) 
EPHEDRINE 
NORMAL SALINE 
Fig. 22. Effect of ~-adrenoceptor stimulating agents (2 x 10-2 mmol/kg) 
on SNAT activity (see table 8) . 
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TABLE 8 
EFFECT OF B-ADRENERGIC SYMPATHOMIMETICS ON SNAT 
ACTIVITY 
PERCENT-
SNAT ACTIVITY AGE 
ROUTE (pmol [14C]_ BOOST DOSE ABOVE SUBSTANCE (mmol/kg) OF ACETYLTRYPTAMINE NORMAL DOSING FORMED/15 MIN/mg 
PiNEAL TISSUE) SALINE (RE -
- S.E.M. LATIVE 
POTENCY) 
ISOPRENALINE 2 x10-2 i.p. 269,5 + 26 107,8 -
ETHYLN ORPHENYL-
EPHRINE " i.p. 21, 5 + 2 8,6 -
FENOTEROL " i.p. 75,8 + 2 3 , 03 -
HEXOPRENALINE " i.p. 42,9 + 2 1,72 -
ORCIPRENALINE " i . p_ 9 ,8 + - 3 3,92 
SALBUTAMOL " i . p. + 5 ,5 - 2 2 ,4 
AMPHETAMINE " i . p. 4,1 + 0 ,5 1,64 -
EPHEDRINE " Lp. 8,0 + 1,5 3,2 -
NORMAL SALINE Lp. 2,5 + 0,5 - 1 
SIGNIFICANCE 
p < 0,0005 
P < 0,0025 
P<0,0005 
P < 0,05 
P<0,005 
P<0 , 0125 
p<0 , 025 
P < 0,01 
not 
significan t 
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ethylnorphenylephrine, which is reputedly a ~1-selective sympatho-
mimetic, also exerts only a small stimulatory effect on SNAT activity. 
It is possible that the pineal ~-receptors are predominantly ~1 in 
nature but that ethylnorphenylephrine does not reach the pineal in 
sufficient amounts or its affinity for pineal ~-receptors is too 10'# 
to e licit a pronounced effect on SNAT levels (fig. 22) . 
The indirectly acting sympathomimetics , amphetamine and ephedrine, 
have the least effect on SNAT activity (f i g . 22) . This coul d be due 
to their inability t o release noradrenaline, the levels of which are 
l ow during the day, from nerve terminals. The slightly greate r 
effect of ephedrine may b e due to a partial direct action which is 
exerted by para-hydroxylated ephedrine which is formed in the liver. 
It is difficult to classify the pineal ~-receptor on the basis of 
the degree of ~-receptor blockade. ~1-Adrenoceptor blocking agents 
such as metoprolol or acebutolol reduced isoprenaline-induced SNAT 
activity s ignifican tly as did non-selective blocking agents s uch as 
isoprenaline and oxprenolol. Butoxamine, a ~2-selective blocking 
agent also caused a significant reduction in SNAT activity (fig. 21), 
strongly suggesting that both ~1 and ~2-type receptors are present. 
This finding d iffers from that of Backstrom (1977) who used an in 
v i tro system to classify pineal ~receptors as predominant l y of the 
~1 type. 
The ~ -sympatholytics used are compared with propranolol in their 
ability to reduce enzyme activity . The ~-sympathomimetics are 
compared with isoprenaline in their ability to stimulate the activity 
of this enzyme. The degree of inhibi tion or stimulation of SNAT 
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activity may depend on many other factors such as lipophilicity, 
intrinsic activity , affinity and metabolism of the substances used 
as well as biological variation among the rats used. 
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CHAPrER 4 
4. 1 DISCUSSION 
An ~ttempt was made to categorize the effects of adreno - a c tive 
substances on the pineal gland by monitoring enzymic changes and to 
establish whether a link exists between these changes and possible 
gonadal effects of these substances. In other words, two main 
lines of attack were planned: ( 1) to determine whether any of the 
pineal enzymes were affected by ~-adreno-active substances and ( 2) 
whether t h is had any effect on the oestrous cycle. The substances 
used were selected as representing the major ~-adrenergic blo oking 
and ~ - stimulating substances used in South Africa. 
4.1.1 SNAT Sensitivity 
I n the various experiments performed, SNAT levels proved to be very 
sensitive to stimulation or inhibition by the substances used. 
Isoprenaline in particul ar, a non-selective , ~ -sympathomimetic agent, 
stimul ated enzyme activity the most effectively . The overal l degree 
of enzyme sensitivity depends not only on the time of d a y, but also 
on the time of year, enzyme act,iv i ty fluctuating seasonally as well 
(Rei t er, 1976) . As the experiments extended over a period of months, 
enzyme activity would probably have fluctuated slightly as a result of 
the seasonal influ ence . This fluctuation is of no consequence in 
eval uating the degree of stimulation or inhibition of the enzyme 
system a s resul ts were compared with concurrently- run controls . 
SNAT appeared to be susceptible to the greatest degree of stimulation 
during the period preceding the onset of the dark phase , the activity 
of the stimulated enzyme increasing as the day progresses . This 
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progressive increase in enzyme sensitivity is accompanied by a 
concomitant increase in the lag period between dosing and onset of 
enzyme induction. The lag period is apparently due to messenger RNA 
being required prior to SNAT activity being increased and this mRNA must 
first be synthesized (Romero ~ al., 1975b). Maintenance of high 
SNAT levels requires continuous occupation of the ~-receptor by an 
agonist. The ~-blockers, which compete with ~-airenoceptor stimulants 
for the receptor sites, exert their effect by displacing the agonist and 
thereby causing reduction in enzyme activity . 
Agents such as fenoterol or salbutamol, which are ~2- selective adrenergic 
stimulants, were less effective than isoprenaline in stimulating enzyme 
activity. Ethylnorphenylephrine, a ~1-selective sympathomimetic, 
showed very little enzyme stimulatory activity. It is quite possible 
therefore that the pineal ~adrenoceptor is of such a nature that an 
agonist or antagonist possessing non-specific characterist i cs is 
required to elicit a response on this receptor. The results obtained 
seem to sUbstantiate this point of view. On the other hand, there 
may be a mixed population of ~1 and ~2 receptors in the pineal. 
Occupation of neither group alone would exert maximal st imulant or 
inhibitory effects. 
Pindolol, a non - selective ~adrenergic blocking agent, proved to be 
most effective in reducing isoprenaline-induced SNAT activity. 
Butoxamine, a ~-selective adrenergic blocker, was also found to be 
a moderately proficient blocking agent. According to the results 
obtained, the more ~1-selective agents were less effective. 
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The receptors of the pineal thus seem to be of mi x ed nature. This 
difference from the results of Backstrom (197?) who classified pineal 
f -receptors as mainly ~1 could be as a result of using an 2.!!. ~ system 
instead of an in vitro one. In the latter system which was used by 
Backstrom, the substances being tested would have had greater accessibility 
to the receptors than is the case with the ~ vivo model. Liver 
degradation and firs t-pass clearance, formation of active metabolites 
and other effects may also be implicated in the difference in results. 
Of the agents used, the ~-adrenoceptor antagonists, in addition to 
their receptor-blocking activ i ty, also possess other properties on 
cardiac tissue such as intrinsic sympathomimetic activity (i.s . a . ), 
membrane stabilizing activ,ity (m.s.a.) and cardioselectivity. Although 
one or more of these effects may be implicated in the overall effect of 
the drug on the pineal, they do not necessarily contribute to such an 
effect. The effect of pindolol and oxprenolol, which possess i.s.a., 
on SNAT activity may however be a combination of blocking activity plus 
this partial agonist effect. 
The age of the animals used was also found to influence the effect of 
adreno-active substances on SNAT activity. Enzyme activity was less 
susceptible to stimulation as the age of the rats increased. This is 
probably due to a decreased seniSitivity of the ~-receptors as discussed 
by Greenberg and Weiss (1978). A decrease, in the number of bio-
chemically active pinealocytes due to calcification with increasing 
age may also be of importance. Other factors such as hepatic blood 
flow, cardiac output and drug-metabolizing enzyme activity may also 
influence the degree of effect of the agents u sed on SNAT activity. 
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Possible variation in the metabolism and distribution of ~-active 
substances or their metabolites by individual animals may also 
contribute to slight differences in the effect of these drugs. These 
variations among the rats used were however limited by using rats from 
one population w~th approximately the same mass and age. 
4.1.2 HIOMT Activity and the Oestrous Cycle 
Although no apparent effect on HIOMT activity Was noted, it is possible 
that ~ -active substances may have exerted an effect on this enzyme 
which could not be detected as such an effect was very small and the 
technique used was relatively insensitive. In view of the fact that 
the diurnal rhythm of HIOMT has a re l atively small fluctuation in 
amplitude, stimulation or inhibition of the production of enzyme 
protein (by variation in light in tensity for example) may alread y 
be occurring at limits approaching the maximum. A ~-active SUbstance 
would thus elicit a negligible effect assuming of course that HIOMT 
activity is controlled by stimulation of the p i neal ~-adrenoceptor. 
One should not rule out the possibility that HIOMT levels are 
controlled by another physiological mechanism such as the dopaminergic 
system or negative feedback by hormones - especially oestrogen. The 
intermediate second messenger sys tem may not be cAMP but cycli c 
guanosine monophosphate (cGMP). If this is the case, it would 
account for the lack of effect by the agents used on HIOMT activity. 
It could be argued that the significant effect of ephedrine on HIOMT 
activity is due to an influence on other centres in the brain. If 
this is the case, one would have expected a similar result with 
amphetamine. As no such effect was found when amphetamine was 
used, some other unknown factors may be present which caused ephedrine 
- 115 -
to act in an inhibitory fashion on the enzyme. 
The pineal exerts a demonstrated antigonadotrophic effect in the rat. 
Wi th the knowledge that 13-acti ve substances mod ify pineal metabolic 
activity, i t seems logical to assume that these substances would 
consequently exert some sort of influence on reproductive physiology. 
The oestrous cycle may be regarded as a fairly u seful parameter for 
monitoring any such gonadal effects. Although, with the exception 
of propranolol, 13-active substances did not influence the oestrous 
cycle to any marked degree, a more intensive study of effects on the 
oestrous cycle may well have produced results from which more absolute 
conclusions would have been drawn. For example, significant change 
in dosage levels, route of administration, time and frequency of dosing 
and proportion of light/dark may well have produced more significant 
results. Unfo!'tunately, this would have requir ed great numbers of 
rats and would have been extremely laborious and time-consuming, thus 
mitigating against extending that line of investigation. Propranolol, 
which did exert some effect on the oestrous cycle, may well have caused 
this effect by a direct action on the hypothalamus OT pituitary or the 
effect may have been due to a combined action on these two areas as 
we ll as on the pineal. However, as the effect of propranolol differed 
during dark and light, this effect on the oestrous cycle seems most 
likely to be pineal-mediated. Propranolol was also a very effective 
blocker of pineal SNAT, thus reinforcing the concept of pineal involve-
ment. 
Aside from any central or pineal-mediated influence of 13-
sympatholytics or sympathomimetics on the oestrous cycle, these 
substances may well influence the oestrou s cycle directly by acting 
on uterine i3-receptors. The effect here depends not only on the 
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species of the animal, but also on the stage of the sexual cycle, 
the stage of gestation i f conception has taken place and the dose 
given. In vitro, sympathomimetics have been shown to contract strips 
of pregnant or non-pregnant uterus. These effects differ in situ 
---
however, making precise predictions of overall effects of ~ -active 
substances on uterine muscle difficult. Just before, and at 
parturition, ~2- selective sympathomimetics have been shown to inhibit 
uterine tone and contractions in vivo. Presumably ~- adrenoceptor 
blocking agen ts would reverse this effect. _ More selective ~2-receptor 
stimul ants such as fenoterol or salbutamol have been used successfully 
to delay premature labour thus adequately demonstrating the effective -
ness of ~ -active agents in inhibiting uterine tone (Liggins and Vaughan, 
1973) • Propranolol may well have affected the oestrous cycle by 
altering uterine tone. 
If one considers the involvement of the pineal in gonadal function, 
it is apparent that from a clinical point of view, administration of 
~ -active substances, which are currently widely used in medicine, may 
have far-reaching secondary effects not yet discovered. This applies 
especial ly to patients taking medication on a long-term basis. 
Examples of such are hypertensive patients taking ~-adrenergic blocking 
agents or asthmatic patients on ~2-adrenergic stimulating agents. It 
is possible that fertility may be affected. The pineal, which has 
many rhythms of its own, may also control other biorhythms and these 
may in turn be affected by adreno-active substances. Interference 
with these rhythms (by blocking them or causing rhythmic phase changes 
for example) may in the long run seriously impair physiological processes 
or behaviours which are of a rhythmic natur e. Rhythmic functions such 
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as sodium excretion, insulin releas e and ACTH release, which are 
endogenous in nature, may be significantly altered, thereby affecting 
mood and drive for example. With light and d.ark having an influence 
on the pineal as well, these potential effects may vary at different 
times of the day thus complicating the issue, this would again lead 
to increased attention to chronopharmacology as opposed to factors such 
as bioavailability. It must also be realised that any such effects of 
adreno-active substances are not necessarily mediated only by the 
pineal. Thay may involve other areas of the brain alone or in 
combination with the pineal or they may work at a more direct level 
on peripheral organs such as the uterus or ovaries. 
In addition to possible gonadal effects, the apparent existence of a 
pineal-adrenal axis and a pineal-thyroid axis as discussed in Chapter 1 
gives rise to speculation on the potential effects of adreno-active 
substances on adrenal and thyroid function and on overall metabolic 
function. Rhythms such as that of corticosterone as we ll as 
production of glucocorticoids, mineralocorticoids and thyroid 
hormones may be markedly influenced. Melatonin for example, is 
known to influence TSH (thyroid stimulating hormone) production. 
~-active substances, which can alter melatonin biosynthesis, are 
thus most likely to exert an effect on TSH. All these potential 
pineal effects may be either direct or via the hypothalamus or 
pitui tary. Overall adrenal and thyroid metabolic effects thus 
suggested may in turn indirectly influence fertility as it is known 
that the thyroid gland for example is implicated in reproductive 
function. Viewed as a whole, pineal involvement in reproductive 
physiology is quite likely to be multi-factorial, a combination of 
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effects on other endocrine systems contributing to an overall effect of 
the pineal. 
4.2 CONCLUSION 
The rat pineal gland is a useful model for studying s ubs tances which 
act on the ~- adrenoceptor. A parameter such as effect on SNAT activity 
may be used to classify such substances in order of potency. The ~ -
receptors appear to be both ~1 and ~2 in nature. HIOMT does not appear 
to respond t o ~-active substances. One can speculate on the likel i hood 
of the sympathetic nervous system not exerting any con trol over this 
enzyme. Alternatively, any alteration in HIOMT levels is of such a 
l ow order that it is not possible to detect it using the existing 
me thod of enzyme assay. 
There does not appear to be a conclusive link between the a lterat ion 
in pineal enzyme activity caused by ~-active sUbstances and an influence 
on the oestrous cycle. As further research in this field i s needed, it 
would be interesting to investigate the poss ib le pineal-mediated effect 
of ~-active substances on adrenal and thyroid function and see if any 
such effects can influence overall body metabolism and gonadal function. 
Instead of the oestrous cycle, one could poss ibly a lso investigate the 
effec t of ~-active substances on other g onadal processes such as 
ovulation or number of foetuses produced. Any research in this 
direction would be well worth the effort as much remains to be lear nt 
about the pineal gland which is indeed a unique organ. Chrono-
pharmacology is now taking its place as a relevant and important field 
of study and it is bound to become even more so in the near future. 
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